<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Metab Brain Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Metab Brain Dis</journal-id>
<journal-title-group>
<journal-title>Metabolic Brain Disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-7490</issn>
<issn pub-type="epub">1573-7365</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28752219</article-id>
<article-id pub-id-type="pmc">5596046</article-id>
<article-id pub-id-type="publisher-id">77</article-id>
<article-id pub-id-type="doi">10.1007/s11011-017-0077-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Morris</surname>
<given-names>Gerwyn</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Puri</surname>
<given-names>Basant K.</given-names>
</name>
<address>
<email>basant.puri@imperial.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frye</surname>
<given-names>Richard E.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label>Tir Na Nog, Bryn Road seaside 87, Llanelli, Wales SA15 2LW UK </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution>Department of Medicine, </institution><institution>Imperial College London, Hammersmith Hospital, </institution></institution-wrap>London, England W12 0HS UK </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 4687 1637</institution-id><institution-id institution-id-type="GRID">grid.241054.6</institution-id><institution>College of Medicine, Department of Pediatrics, </institution><institution>University of Arkansas for Medical Sciences, Arkansas Children’s Hospital Research Institute, </institution></institution-wrap>Little Rock, AR 72202 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>27</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<volume>32</volume>
<issue>5</issue>
<fpage>1335</fpage>
<lpage>1355</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The conceptualisation of autistic spectrum disorder and Alzheimer’s disease has undergone something of a paradigm shift in recent years and rather than being viewed as single illnesses with a unitary pathogenesis and pathophysiology they are increasingly considered to be heterogeneous syndromes with a complex multifactorial aetiopathogenesis, involving a highly complex and diverse combination of genetic, epigenetic and environmental factors. One such environmental factor implicated as a potential cause in both syndromes is aluminium, as an element or as part of a salt, received, for example, in oral form or as an adjuvant. Such administration has the potential to induce pathology via several routes such as provoking dysfunction and/or activation of glial cells which play an indispensable role in the regulation of central nervous system homeostasis and neurodevelopment. Other routes include the generation of oxidative stress, depletion of reduced glutathione, direct and indirect reductions in mitochondrial performance and integrity, and increasing the production of proinflammatory cytokines in both the brain and peripherally. The mechanisms whereby environmental aluminium could contribute to the development of the highly specific pattern of neuropathology seen in Alzheimer’s disease are described. Also detailed are several mechanisms whereby significant quantities of aluminium introduced via immunisation could produce chronic neuropathology in genetically susceptible children. Accordingly, it is recommended that the use of aluminium salts in immunisations should be discontinued and that adults should take steps to minimise their exposure to environmental aluminium.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Brain</kwd>
<kwd>Neuropathology</kwd>
<kwd>Aluminum</kwd>
<kwd>Alzheimer disease</kwd>
<kwd>Autism spectrum disorder</kwd>
<kwd>Autoimmunity</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Imperial College London</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media, LLC 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Autism spectrum disorder (ASD) refers to an increasingly common group of heterogeneous disorders identified by the presence of impairments in social interactions and communication together with a restrictive range of repetitive and stereotypical behaviours (Zhubi et al. <xref ref-type="bibr" rid="CR293">2014</xref>; Ladd-Acosta et al. <xref ref-type="bibr" rid="CR135">2014</xref>). Recent analyses have consistently shown that the prevalence of ASD is increasing. Estimates vary between one in 68 (CDC) and one in 46 (Pelly et al. <xref ref-type="bibr" rid="CR206">2015</xref>) to one in 38 (Kim et al. <xref ref-type="bibr" rid="CR118">2011</xref>) during similar time periods. There is some debate as to the reasons for the precipitous increase in prevalence of ASD over the past two decades, with some concluding that this is essentially an artefact stemming from the development of broader diagnostic categories and increased medical awareness (Rutter <xref ref-type="bibr" rid="CR231">2005</xref>; King and Bearman <xref ref-type="bibr" rid="CR119">2009</xref>). However, analyses conducted by other research teams have suggested that other factors aside from diagnostic shift may contribute to this increase in prevalence (Grether et al. <xref ref-type="bibr" rid="CR83">2009</xref>; Hertz-Picciotto <xref ref-type="bibr" rid="CR96">2009</xref>). Although early heritability estimates for ASD were high (approximately 97%), multiple comprehensive genetic studies have failed to reveal reproducible candidate genes, and thus far no single gene can account for more than 1% of ASD cases, although there is a great deal of evidence that genetic abnormalities play a major role in the development of the disorders which is unsurprising given that this is the case with most if not all illnesses (Siniscalco et al. <xref ref-type="bibr" rid="CR244">2013</xref>). It is also worth noting that only a minority of children with an ASD diagnosis have an identifiable genetic syndrome (Siniscalco et al. <xref ref-type="bibr" rid="CR244">2013</xref>) and recent studies suggest that the yield of genetic testing is low even when chromosomal microarray analysis is combined with whole exome sequencing, particularly in non-dysmorphic ASD children (Tammimies et al. <xref ref-type="bibr" rid="CR256">2015</xref>). Moreover, some genetic abnormalities which increase the risk of developing ASD are also risk factors for other neurodevelopmental or neuroimmune conditions, and are polymorphisms rather than deleterious mutations, being also present in unaffected individuals (Betancur <xref ref-type="bibr" rid="CR23">2011</xref>; Sahoo et al. <xref ref-type="bibr" rid="CR232">2011</xref>). It would appear that these genes appear to confer vulnerability to a variety of neurodevelopmental disorders (Betancur <xref ref-type="bibr" rid="CR23">2011</xref>; Sahoo et al. <xref ref-type="bibr" rid="CR232">2011</xref>; Rapoport et al. <xref ref-type="bibr" rid="CR224">2012</xref>). Furthermore, a recent heritability estimate stemming from the largest twin study to date yielded a figure as low as 37% (Hallmayer et al. <xref ref-type="bibr" rid="CR89">2011</xref>), although another recent study calculated an estimate of heritability between 40 and 60% (Klei et al. <xref ref-type="bibr" rid="CR120">2012</xref>).</p>
<p id="Par3">The concept of ASD as an illness of purely genetic origin has given way to the view that, at the very least, the aetiopathogenesis of ASD involves a highly complex interaction between numerous genes and environmental risk factors (Bushnell <xref ref-type="bibr" rid="CR33">2013</xref>; LaSalle <xref ref-type="bibr" rid="CR140">2013</xref>). Moreover, it is becoming increasingly apparent that alterations in the epigenetic landscape and dysregulation of epigenetic mechanisms responsible for gene expression also play a major role in the aetiopathogenesis of these disorders (Rangasamy et al. <xref ref-type="bibr" rid="CR223">2013</xref>; Flashner et al. <xref ref-type="bibr" rid="CR69">2013</xref>; Siniscalco et al. <xref ref-type="bibr" rid="CR244">2013</xref>). In a landmark post-mortem microarray study, Voineagu and fellow workers identified 444 genes which were differentially expressed in the cerebral cortex, and two genes which were differentially expressed in the cerebellum, of children with ASD compared with neurotypical age- and sex-matched controls. They reported that the dysregulated patterns of expression of immune and glial gene markers were not associated with any known ASD risk genes, so that immune changes are likely to be either secondary phenomena or the result of environmental factors (Voineagu et al. <xref ref-type="bibr" rid="CR271">2011</xref>). In another study, Melnyk and others examined 68 ASD subjects, 40 unaffected siblings and 54 age- and sex-matched controls, and reported oxidative damage to DNA (indexed by the oxidised DNA adduct 8-oxo-deoxyguanosine) and proteins in leukocytes combined with global DNA hypomethylation that was specific to ASD children (Melnyk et al. <xref ref-type="bibr" rid="CR170">2012</xref>). The phenomenon of global DNA hypomethylation in the brain as a driver of altered gene expression in ASD children has also been reported (Ladd-Acosta et al. <xref ref-type="bibr" rid="CR135">2014</xref>; Nardone et al. <xref ref-type="bibr" rid="CR194">2014</xref>). It is also of interest that the latter team reported hypomethylation and consequent upregulation of complement and tumour necrosis factor-alpha (TNF-α) genes, which are involved in the regulation of the neurodevelopmental roles of microglia and synaptic scaling respectively (Nardone et al. <xref ref-type="bibr" rid="CR194">2014</xref>).</p>
<p id="Par4">Further evidence emphasising the importance of epigenetic abnormalities in the pathogenesis of ASD was published by Wong and fellow workers (<xref ref-type="bibr" rid="CR278">2014</xref>). These authors reported differently methylated DNA regions within 50 monozygotic twin pairs (i.e. 100 individuals) discordant for ASD that correlated with the severity of autistic trait scores, emphasising the importance of epigenetic rather than genetic factors in the pathophysiology and pathogenesis of ASD (Wong et al. <xref ref-type="bibr" rid="CR278">2014</xref>). The role of epigenetic dysregulation as an important factor in the pathogenesis of ASD is further supported by evidence of dysregulated microRNA (miRNA) expression in ASD children (Mundalil Vasu et al. <xref ref-type="bibr" rid="CR187">2014</xref>; Mellios and Sur <xref ref-type="bibr" rid="CR169">2012</xref>). A recent post-mortem study cited evidence of hypomethylated and upregulated miR-142 in the frontal cortex (Brodmann area 10) in children with ASD, which is of interest as this miRNA plays a major role in regulating the neurodevelopmental activities of microglia and maintaining them in a quiescent state (Mor et al. <xref ref-type="bibr" rid="CR176">2015</xref>; Vaishnavi et al. <xref ref-type="bibr" rid="CR264">2013</xref>; Marrale et al. <xref ref-type="bibr" rid="CR164">2014</xref>).</p>
<p id="Par5">When viewed as a whole, it appears that the aetiology of ASD is multifactorial, involving a highly complex and diverse combination of genetic, epigenetic, environmental and immunological factors (Flashner et al. <xref ref-type="bibr" rid="CR69">2013</xref>; Herbert <xref ref-type="bibr" rid="CR95">2010</xref>; Roberts et al. <xref ref-type="bibr" rid="CR226">2013</xref>). Overall, the conceptualisation of ASD has undergone a paradigm shift, and rather than being viewed as a single illness with a unitary pathogenesis and pathophysiology, it is a clinically heterogeneous syndrome with a complex multifactorial aetiopathogenesis (Zhubi et al. <xref ref-type="bibr" rid="CR293">2014</xref>; Voineagu et al. <xref ref-type="bibr" rid="CR271">2011</xref>; Betancur <xref ref-type="bibr" rid="CR23">2011</xref>; Tordjman et al. <xref ref-type="bibr" rid="CR261">2014</xref>; Ruggeri et al. <xref ref-type="bibr" rid="CR230">2014</xref>; Georgiades et al. <xref ref-type="bibr" rid="CR77">2013</xref>). Ultimately, the pathology in any given child likely has its origins in a dynamic interplay between a broad range of different environmental agents, predisposing genetic factors and complex epigenetic mechanisms as discussed above (Zhubi et al. <xref ref-type="bibr" rid="CR293">2014</xref>; Voineagu et al. <xref ref-type="bibr" rid="CR271">2011</xref>; Betancur <xref ref-type="bibr" rid="CR23">2011</xref>; Tordjman et al. <xref ref-type="bibr" rid="CR261">2014</xref>; Ruggeri et al. <xref ref-type="bibr" rid="CR230">2014</xref>; Georgiades et al. <xref ref-type="bibr" rid="CR77">2013</xref>).</p>
<p id="Par6">The view of ASD as an illness or illnesses exclusively affecting the brain is also changing. While many ASD children display evidence of activated microglia and astrocytes, which are characteristic of many neuroimmune and neurodegenerative diseases (Morgan et al. <xref ref-type="bibr" rid="CR179">2012</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR253">2013</xref>; Morgan et al. <xref ref-type="bibr" rid="CR178">2010</xref>; Morris and Berk <xref ref-type="bibr" rid="CR180">2015</xref>; Morris et al. <xref ref-type="bibr" rid="CR184">2015a</xref>), there is also copious evidence of abnormalities in the peripheral immune system. Such evidence includes data demonstrating excessive pro-inflammatory cytokine (PIC) expression, reduced anti-inflammatory cytokine expression, modulated or increased T-cell responses, altered natural killer T-cell responses, activated complement responses, major histocompatibility complex (MHC) class I abnormalities and increased autoantibodies in the periphery as well as in the brain (reviewed in Noriega and Savelkoul <xref ref-type="bibr" rid="CR198">2014</xref>; Careaga and Ashwood <xref ref-type="bibr" rid="CR34">2012</xref>; Estes and McAllister <xref ref-type="bibr" rid="CR61">2015</xref>; Gottfried et al. <xref ref-type="bibr" rid="CR82">2015</xref>). The pattern of single nucleotide polymorphisms (SNPs) in immune genes is similar to those seen in several autoimmune diseases such as multiple sclerosis (MS) (Ramos et al. <xref ref-type="bibr" rid="CR222">2012</xref>). There is also evidence of abnormally robust pattern recognition receptor activity linked to the presence of SNPs in encoding genes leading to exaggerated immune responses (Enstrom et al. <xref ref-type="bibr" rid="CR59">2010</xref>; Mead and Ashwood <xref ref-type="bibr" rid="CR168">2015</xref>). It is also noteworthy that genes governing immune and inflammatory responses are upregulated in some children with an ASD diagnosis (Koufaris and Sismani <xref ref-type="bibr" rid="CR129">2015</xref>) and that the presence of such abnormally expressed genes can predict the development of ASD in male children with some 83% accuracy (Pramparo et al. <xref ref-type="bibr" rid="CR220">2015</xref>). It is also of interest that polymorphisms in cytokine and HLA genes are associated with unusual responses to vaccines (Castiblanco and Anaya <xref ref-type="bibr" rid="CR35">2015</xref>). The evidence of immune abnormalities in many, but by no means all, children afforded an ASD diagnosis has led to the proposal of a neuroimmune subtype of ASD (McDougle et al. <xref ref-type="bibr" rid="CR167">2015</xref>). Furthermore, several researchers have reported an association between initial inflammatory insults and the subsequent development of chronic immune disturbances in ASD children (McDougle et al. <xref ref-type="bibr" rid="CR167">2015</xref>; Gottfried et al. <xref ref-type="bibr" rid="CR82">2015</xref>; Siniscalco et al. <xref ref-type="bibr" rid="CR244">2013</xref>). One possible explanation for this phenomenon is that an unusually potent and/or prolonged immune response allows for the development of macromolecular or tissue damage leading to the formation of damage-associated molecular patterns (DAMPs) (Lucas et al. <xref ref-type="bibr" rid="CR152">2015</xref>). The formation of such DAMPs and the resultant chronic stimulation of pattern recognition receptors (PRRs), leading to the development of an “autotoxic loop” of increasing inflammation and oxidative stress, is considered to play a major role in the maintenance and exacerbation of systemic inflammation, neuro-inflammation and neurodegeneration in a range of autoimmune and neurodegenerative diseases such as systemic lupus erythematosus (SLE), MS and Alzheimer’s disease (AD) (Venegas and Heneka <xref ref-type="bibr" rid="CR266">2017</xref>; Land <xref ref-type="bibr" rid="CR137">2015</xref>). Frequent or prolonged postnatal infections are an obvious source of inflammatory insults and such events appear to be associated with a significantly increased risk of developing ASD (Abdallah et al. <xref ref-type="bibr" rid="CR1">2012</xref>; Hadjkacem et al. <xref ref-type="bibr" rid="CR88">2016</xref>). However, other environmental agents putatively associated with an increased risk of developing the ASD phenotype, such as organophosphates, mercury and aluminium, also have the capacity to provoke a prolonged and or exaggerated immune response (Eisenkraft et al. <xref ref-type="bibr" rid="CR56">2013</xref>; Kern et al. <xref ref-type="bibr" rid="CR114">2016</xref>; Shaw and Tomljenovic <xref ref-type="bibr" rid="CR239">2013</xref>). Aluminium salts in adjuvant form functioning as DAMPs activate PRRs and exert profound stimulatory effects on innate immune responses (Powell et al. <xref ref-type="bibr" rid="CR218">2015</xref>) and thus could be candidates for the generation of tissue damage and DAMP formation in children with an underlying tendency to produce an exaggerated immune response. There is also evidence of increased aluminium levels in the hair and urine of ASD children compared with unaffected controls (Yasuda and Tsutsui <xref ref-type="bibr" rid="CR281">2013</xref>; Mohamed Fel et al. <xref ref-type="bibr" rid="CR173">2015</xref>; Blaurock-Busch et al. <xref ref-type="bibr" rid="CR28">2012</xref>; Blaurock-Busch et al. <xref ref-type="bibr" rid="CR27">2011</xref>), although this not an invariant finding (Fido and Al-Saad <xref ref-type="bibr" rid="CR68">2005</xref>; Al-Ayadhi <xref ref-type="bibr" rid="CR7">2005</xref>). It should also be noted that aluminium adjuvants are becoming a recognised trigger of autoimmune pathology in genetically susceptible individuals (Morris et al. <xref ref-type="bibr" rid="CR185">2015b</xref>).</p>
<p id="Par7">Intriguingly, chronic or cumulative exposure to aluminium reflected by increased levels in cerebrospinal fluid (CSF) and serum may be one environmental factor in the pathogenesis and pathophysiology of MS, Parkinson’s disease (PD) and AD (Fulgenzi et al. <xref ref-type="bibr" rid="CR75">2014</xref>; Exley et al. <xref ref-type="bibr" rid="CR65">2006</xref>; Ahmed and Santosh <xref ref-type="bibr" rid="CR6">2010</xref>; Yasui et al. <xref ref-type="bibr" rid="CR282">1992</xref>; Exley and Vickers <xref ref-type="bibr" rid="CR64">2014</xref>; Basun et al. <xref ref-type="bibr" rid="CR20">1991</xref>). There is a wealth of research examining the potential association between increased exposure to environmental aluminium and the development of the last of these illnesses. Indeed, a recent meta-analysis involving eight cohort- and case-controlled studies conducted prior to 2015 involving 10,567 participants concluded that increased aluminium exposure increased the risk of developing AD by some 71% (Wang et al. <xref ref-type="bibr" rid="CR276">2016</xref>). This seems a noteworthy finding in the light of evidence indicating that AD is also an aetiologically heterogeneous syndrome (Lam et al. <xref ref-type="bibr" rid="CR136">2013</xref>; Morris and Berk <xref ref-type="bibr" rid="CR180">2015</xref>) as indeed is the case for PD (Klein and Lohmann <xref ref-type="bibr" rid="CR121">2009</xref>; Korczyn and Hassin-Baer <xref ref-type="bibr" rid="CR128">2015</xref>) and MS (Paz Soldan and Rodriguez <xref ref-type="bibr" rid="CR204">2002</xref>). Hence establishing an association between AD and a single environmental factor in a cross-sectional study when a multiplicity of such factors may be involved in different patients is a difficult enterprise. Much of the <italic>in vivo</italic> evidence examining the mechanisms underpinning the pathological effects of aluminium exposure has been obtained in the area of human and animal research into the pathogenesis of AD. Such evidence includes the induction of oxidative stress, mitochondrial dysfunction, microglial activation and functional dysregulation of microglia (Morris and Berk <xref ref-type="bibr" rid="CR181">2016</xref>). This may be highly relevant as many children with ASD also manifest oxidative stress (reviewed in Depino <xref ref-type="bibr" rid="CR48">2013</xref>; Rossignol and Frye <xref ref-type="bibr" rid="CR228">2014</xref>; Frustaci et al. <xref ref-type="bibr" rid="CR73">2012</xref>), mitochondrial dysfunction (reviewed by Goh et al. <xref ref-type="bibr" rid="CR80">2014</xref>; Chen et al. <xref ref-type="bibr" rid="CR39">2015</xref>; Guevara-Campos et al. <xref ref-type="bibr" rid="CR85">2013</xref>) and abnormal microglial activity as discussed above.</p>
<p id="Par8">In this paper we aim to review the available evidence purporting to establish an association between increased aluminium exposure and an increased risk of developing AD and the evidence aimed at illuminating the potential pathophysiological mechanisms by which aluminium could be an element in the development of the illness in at least some people. The objective of this part of the paper is to inform readers with an interest in the pathogenesis and pathophysiology of ASD who might not be aware of concerns regarding aluminium in the pathogenesis of conditions other than ASD. We also aim to highlight accumulating evidence suggesting that aluminium adjuvants can precipitate serious autoimmune or auto-inflammatory pathology in genetically susceptible people which is a growing area of concern. We will then move on to consider evidence suggesting an association between the increased use of aluminium salt adjuvants and an increased incidence of ASD before moving on to touch briefly on the safety or otherwise of vaccines in people with a predisposition to autoimmunity and a range of polymorphisms in immune genes. This would appear to be appropriate in the light of changes in the conceptualisation of ASD as a syndrome with a multiplicity of potential causes and increasing knowledge regarding the effects of genetic variation in the immune system and the response to vaccines. The remainder of the paper will focus on mechanisms by which increased exposure to aluminium could be an environmental trigger of ASD in at least some children with a range of abnormalities in the performance of their immune systems.</p>
</sec>
<sec id="Sec2">
<title>Section 1. Evidence highlighting the neurotoxic properties of aluminium</title>
<sec id="Sec3">
<title>Evidence of an association between chronic aluminium exposure and the development of AD</title>
<p id="Par9">The <italic>p</italic>-block metal aluminium, which is the third most frequently occurring element in the Earth’s crust, occurs naturally in the ore bauxite, various clays and alumino-silicate minerals, and has a preferred oxidation state of +3. Several authors have reported a strong positive correlation between the level of aluminium in drinking water and the incidence of AD throughout the world including the United Kingdom, Canada, Norway and France (Flaten <xref ref-type="bibr" rid="CR70">2001</xref>; Kawahara and Kato-Negishi <xref ref-type="bibr" rid="CR113">2011</xref>). The most recently reported association was published by Rondeau et al. (<xref ref-type="bibr" rid="CR227">2009</xref>), who demonstrated that high daily consumption of aluminium in drinking water was associated with a significantly increased risk of developing mild cognitive impairment or AD in a 15-year longitudinal French cohort study involving 1925 recruits (Rondeau et al. <xref ref-type="bibr" rid="CR227">2009</xref>).</p>
<p id="Par10">There is considerable <italic>in vitro</italic> and <italic>in vivo</italic> evidence demonstrating that aluminium ions inhibit the dephosphorylation of tau, potentiate the development of neurofibrillary tangles (NFTs), cause the accumulation of amyloid beta protein and accelerate the formation of amyloid plaques (Kawahara <xref ref-type="bibr" rid="CR112">2005</xref>; Exley <xref ref-type="bibr" rid="CR62">2005</xref>). Despite such evidence, the enthusiasm for aluminium as a factor in the pathogenesis of AD waned largely based on data suggesting that aluminium levels were no higher in the brains of AD patients than in healthy controls, and the failure to detect aluminium in NFTs and amyloid plaques in post-mortem tissue at higher levels in AD than in age- and sex-matched controls (Yumoto et al. <xref ref-type="bibr" rid="CR285">2009</xref>). In particular, no evidence of increased brain aluminium levels in AD was found, using flameless atomic absorption spectrophotometry, in the study of Jacobs et al. (<xref ref-type="bibr" rid="CR106">1989</xref>). Furthermore, high aluminium levels in the cores of amyloid or neuritic (senile) plaques have not been reported in several studies variously employing scanning proton microprobe analysis (Lovell et al. <xref ref-type="bibr" rid="CR148">1993</xref>), energy-dispersive X-ray microprobe analysis (Jacobs et al. <xref ref-type="bibr" rid="CR106">1989</xref>), electron microprobe analysis (Chafi et al. <xref ref-type="bibr" rid="CR37">1991</xref>) or nuclear microscopy using particle-induced X-ray emission, Rutherford backscattering spectrometry and scanning transmission ion microscopy (Landsberg et al. <xref ref-type="bibr" rid="CR138">1992</xref>). In contrast, increased plaque core aluminium has been reported in AD using an energy-dispersive X-ray microanalytical system (Edwardson et al. <xref ref-type="bibr" rid="CR54">1986</xref>) and a method based on inductively coupled plasma mass spectrometry combined with flow injection (Beauchemin and Kisilevsky <xref ref-type="bibr" rid="CR21">1998</xref>). Similarly, the findings in relation to increased aluminium in NFTs are inconsistent, with a positive finding using laser microprobe mass analysis (Good et al. <xref ref-type="bibr" rid="CR81">1992</xref>), negative findings using electron microprobe and ion microprobe analyses (Chafi et al. <xref ref-type="bibr" rid="CR37">1991</xref>) and an intermediate finding (that is, slight increase) again using laser microprobe mass analysis (Lovell et al. <xref ref-type="bibr" rid="CR148">1993</xref>). A histochemical study of AD hippocampal neurones reported evidence of aluminium in nucleoli and in NFTs (Walton <xref ref-type="bibr" rid="CR272">2006</xref>).</p>
<p id="Par11">Notwithstanding the above findings, some recent research studies using more sensitive techniques have detected aluminium in the brains of AD patients within plaques, NFTs and elsewhere at significantly higher levels than in age- and sex-matched unaffected controls (Yumoto et al. <xref ref-type="bibr" rid="CR285">2009</xref>; Bouras et al. <xref ref-type="bibr" rid="CR31">1997</xref>). Furthermore, a number of studies reporting the effects of aluminium exposure in animals have demonstrated the development of AD and Alzheimer-like pathology in rodents (Al-Olayan et al. <xref ref-type="bibr" rid="CR11">2015</xref>; Abd-Elghaffar et al. <xref ref-type="bibr" rid="CR2">2005</xref>; Sumathi et al. <xref ref-type="bibr" rid="CR252">2015</xref>; Lu et al. <xref ref-type="bibr" rid="CR150">2014</xref>; Exley and Vickers <xref ref-type="bibr" rid="CR64">2014</xref>; Exley and Esiri <xref ref-type="bibr" rid="CR63">2006</xref>). Animal studies have also revealed that aluminium administered orally or via injection significantly decreased reduced glutathione levels and the activities of catalase, superoxide dismutase, glutathione peroxidase and glutathione reductase, and increased the levels of nitric oxide (NO), PICs and lipid peroxidation (Sumathi et al. <xref ref-type="bibr" rid="CR252">2015</xref>; Al-Olayan et al. <xref ref-type="bibr" rid="CR11">2015</xref>). Moreover, histological examination has revealed apoptosis of hippocampal and cerebral cortical neurones and the presence of NFTs, amyloid plaque deposition, Schwann cell degeneration and nerve fibre demyelination (Abd-Elghaffar et al. <xref ref-type="bibr" rid="CR2">2005</xref>).</p>
<p id="Par12">Knowledge regarding the possible mechanisms by which aluminium exposure could provoke some of the characteristic features underpinning the pathophysiology of AD has also evolved. In a recent paper, Zhao et al. (<xref ref-type="bibr" rid="CR292">2014</xref>) reported on the ability of physiologically realistic levels of aluminium to provoke the aggregation of Aβ42 monomers into dimeric, oligomeric, and ultimately fibrillary structures. This team of authors also cited decreased expression of triggering receptor expressed in myeloid/microglial cells-2 (TREM2) in microglia subsequent to the upregulation of miR-34a as the mechanism underpinning impaired microglial-mediated clearance of Aβ42 peptides from the brain caused by prolonged exposure to aluminium at nanomolar concentrations (Zhao et al. <xref ref-type="bibr" rid="CR292">2014</xref>).</p>
<p id="Par13">Human <italic>in vivo</italic> studies have also reported specific aluminium-related abnormalities in the brains of AD patients. The association between prolonged exposure to environmental aluminium and increased levels of phosphorylated tau subspecies in blood lymphocytes has also been reported in a recent study involving 66 retired aluminium workers (Lu et al. <xref ref-type="bibr" rid="CR150">2014</xref>). Moreover, it has been demonstrated that ferritin in plasma from AD patients, particularly those with mild AD, contains significantly higher concentrations of aluminium compared with plasma ferritin from age- and sex-matched controls which, given the pivotal role of this protein in the regulation of metal homeostasis, may be a crucial finding; the finding of a higher level in mild AD compared with severe AD may also point to a first phase in which there is an aluminium overload of ferritin, followed by a phase in which ferritin with reduced functional capacity releases aluminium (De Sole et al. <xref ref-type="bibr" rid="CR47">2013</xref>). Interestingly, the capacity of aluminium to disrupt the activity of ferritin and transferrin, with the subsequent disruption of iron homeostasis, has been demonstrated in a series of studies implicating aluminium as a potential causative agent in certain types of breast cancer cells as well as in primary invasive breast cancers and ductal carcinoma <italic>in situ</italic> (Darbre et al. <xref ref-type="bibr" rid="CR46">2013</xref>; Darbre et al. <xref ref-type="bibr" rid="CR45">2011</xref>; Mannello et al. <xref ref-type="bibr" rid="CR161">2013</xref>).</p>
<p id="Par14">It should also be noted that, until recently, an explanation which could explain the selective effects of AD on various regions of the brain was lacking. However, in a study using electrothermal atomic absorption spectroscopy of the aluminium content of the arterial walls of eight arteries which supply the brain, it was found that aluminium concentration is far higher in the posterior cerebral artery (arteria cerebri posterior), which supplies the hippocampus, in late-stage AD patients than in age- and sex-matched controls (Bhattacharjee et al. <xref ref-type="bibr" rid="CR24">2013</xref>). This study is particularly intriguing because, when taken as a whole, the data indicate the presence of biochemical mechanisms in the endothelial cells supplying the cerebral vasculature which enable the binding of aluminium to selected areas such as the hippocampus, known to play a major role in the pathogenesis of the illness (Bhattacharjee et al. <xref ref-type="bibr" rid="CR24">2013</xref>).</p>
<p id="Par15">There is little doubt that the weight of evidence implicating aluminium in the causation of AD in at least some patients is increasing. However, at the current time, despite an analysis using Hill’s causality criteria concluding that aluminium played a causative role in the development of AD (Walton <xref ref-type="bibr" rid="CR274">2014</xref>), there is currently no universal consensus on the subject, and it seems reasonable to conclude that there is a correlative link between aluminium and AD but that this association does not currently amount to a causative relationship. There is, however, an accumulating body of evidence suggesting that that aluminium in adjuvant form may provoke systematic and symptomatic autoimmune conditions in genetically susceptible individuals and we will now discuss this phenomenon.</p>
</sec>
<sec id="Sec4">
<title>The involvement of aluminium adjuvants in the development of autoimmune syndrome induced by adjuvants (ASIA)</title>
<p id="Par16">Evidence demonstrating the development of chronic autoimmune or auto-inflammatory conditions following environmental exposure to aluminium salts, and indeed other adjuvants, is increasingly becoming a cause for concern (Zafrir et al. <xref ref-type="bibr" rid="CR286">2012</xref>; Cerpa-Cruz et al. <xref ref-type="bibr" rid="CR36">2013</xref>; Jensen-Jarolim <xref ref-type="bibr" rid="CR107">2015</xref>; Willhite et al. <xref ref-type="bibr" rid="CR277">2014</xref>). Much of this evidence has been presented in the context of the “autoimmune (auto-inflammatory) syndrome induced by adjuvants” (ASIA), which encompasses a broad spectrum of immune-mediated illnesses triggered by exposure to medical, cosmetic or environmental adjuvants such as aluminium salts, silicon compounds or indoor mould (Agmon-Levin et al. <xref ref-type="bibr" rid="CR3">2009</xref>). ASIA is characterised by specific and non-specific manifestations of autoimmune disease such as chronic fatigue, myalgia, arthralgias, neurocognitive impairment, respiratory symptoms, gastrointestinal symptoms, dermatological signs and the development of autoantibodies (Israeli <xref ref-type="bibr" rid="CR105">2012</xref>).</p>
<p id="Par17">Medical conditions considered by some to be part of the syndrome include post-vaccination phenomena, Gulf War syndrome, macrophagic myofasciitis, antiphospholipid syndrome, siliconosis and possibly chronic fatigue syndrome (myalgic encephalomyelitis) and fibromyalgia syndrome (Cruz-Tapias et al. <xref ref-type="bibr" rid="CR42">2013</xref>; Vera-Lastra et al. <xref ref-type="bibr" rid="CR267">2013</xref>). It is interesting to note that data from animal models suggest that adjuvants may play a role in the development of syndromic autoimmune diseases such as SLE, Sjögren’s syndrome and rheumatoid arthritis in some patients (Cruz-Tapias et al. <xref ref-type="bibr" rid="CR42">2013</xref>; Bagavant et al. <xref ref-type="bibr" rid="CR18">2014</xref>).</p>
<p id="Par18">Adjuvants were once thought to pose little or no independent threat as drivers of pathology. Unfortunately, studies of animal models and humans have demonstrated the ability of some of them to induce autoimmunity and immune-mediated diseases (Agmon-Levin et al. <xref ref-type="bibr" rid="CR3">2009</xref>; Elkayam et al. <xref ref-type="bibr" rid="CR16">2011</xref>). The mechanisms underpinning adjuvant-induced immunotoxicity appear to be somewhat varied, but clearly impinge on both innate and humoral immune responses (Marrack et al. <xref ref-type="bibr" rid="CR163">2009</xref>; Kool et al. <xref ref-type="bibr" rid="CR124">2008a</xref>; Eisenbarth et al. <xref ref-type="bibr" rid="CR55">2008</xref>). It must be stated however that adjuvant exposure <italic>per se</italic> does not appear to cause problems for the vast majority of people and the development of ASIA seems to depend on genetic predisposition or as yet undetermined environmental co-factors (Perricone et al. <xref ref-type="bibr" rid="CR208">2013</xref>; Esposito et al. <xref ref-type="bibr" rid="CR60">2014</xref>; Shoenfeld and Agmon-Levin <xref ref-type="bibr" rid="CR241">2011</xref>; Soriano et al. <xref ref-type="bibr" rid="CR247">2015</xref>).</p>
<p id="Par19">Several authors have examined patients diagnosed with autoimmune or other immune-mediated illnesses following hepatitis B virus immunisation (Zafrir et al. <xref ref-type="bibr" rid="CR286">2012</xref>; Agmon-Levin et al. <xref ref-type="bibr" rid="CR3">2009</xref>; Agmon-Levin et al. <xref ref-type="bibr" rid="CR4">2014</xref>). The largest such study evaluated the medical records of 93 patients and reported prevalence rates of different manifestations as follows: neurological 67%; general symptoms 60%; musculoskeletal 60%; gastrointestinal 51%; fatigue 42%, ophthalmological 32%; muco-cutaneous 30%; sleep disturbance 19%; psychiatric 16%; and local reactions 11% (Zafrir et al. <xref ref-type="bibr" rid="CR286">2012</xref>). Elevated autoantibody titres were also documented in the sera in 80% of the patients. Several vaccine adjuvants have also been implicated in the development of autoimmune diseases which lie outside ASIA, notably ASD which is a subject that we now consider.</p>
</sec>
<sec id="Sec5">
<title>Aluminium adjuvants in the pathogenesis of ASD</title>
<p id="Par20">From the perspective of aluminium adjuvants as a potential contributory factor in the development of ASD (Shaw and Tomljenovic <xref ref-type="bibr" rid="CR239">2013</xref>), a recent analysis applying Hill’s criteria for establishing causality reported children living in countries with the highest prevalence of ASD appear to have the greatest exposure to vaccine based aluminium. Perhaps more importantly, the increase in exposure to aluminium adjuvants displayed a significant positive correlation with the increased prevalence of ASD in the USA recorded over the last 20 years (<italic>r</italic> = 0.92, <italic>p</italic> &lt; 0.0001). A wider analysis revealed the presence of significant positive correlation between the levels of aluminium in adjuvant form administered to preschool children at around three to four months old and the existing ASD prevalence in seven major Western countries (<italic>r</italic> = 0.89 to 0.94, <italic>p</italic> = 0.0018 to 0.0248) (Shaw and Tomljenovic <xref ref-type="bibr" rid="CR239">2013</xref>).</p>
<p id="Par21">Taylor and colleagues, in a meta-analysis of 10 pre-selected predominantly retrospective studies, reported no causal relationship between a range of mercury containing vaccines and a range of neurodevelopmental conditions such as pervasive developmental delay (PDD), attention-deficit hyperactivity disorder (ADHD), autistic disorder and ASD as diagnosed by several different criteria (Taylor et al. <xref ref-type="bibr" rid="CR258">2014</xref>).</p>
<p id="Par22">It is worth noting that the questions asked by the above two groups are different, with the first focusing entirely on autism using current diagnostic criteria while the second used a range of different case definitions of autism and autism-like conditions and also included children with PDD. Indeed, one large study included in the analysis focused entirely on PDD (Smeeth et al. <xref ref-type="bibr" rid="CR246">2004</xref>), while another two focused on general neurodevelopmental conditions (Andrews et al. <xref ref-type="bibr" rid="CR13">2004</xref>; Verstraeten et al. <xref ref-type="bibr" rid="CR268">2003</xref>). It is also fair to say that the conclusions of another study (DeStefano <xref ref-type="bibr" rid="CR49">2007</xref>) have been challenged and a re-analysis of the data has revealed a significant association between a first measles, mumps and rubella (MMR) immunisation before the age of 36 months in African-American males and a diagnosis of ASD (Hooker <xref ref-type="bibr" rid="CR100">2014</xref>), although it should be noted that this last study has since been retracted. It would appear that the statisticians involved in the meta-analysis by Taylor et al. (<xref ref-type="bibr" rid="CR258">2014</xref>) viewed PDD, ADHD and ASD as essentially the same condition, or, the interpretation of this and other data is based on the concept of ASD as a discrete disease entity which is being increasingly called into question (Zhubi et al. <xref ref-type="bibr" rid="CR293">2014</xref>; Voineagu <xref ref-type="bibr" rid="CR269">2012</xref>; Betancur <xref ref-type="bibr" rid="CR23">2011</xref>; Tordjman et al. <xref ref-type="bibr" rid="CR261">2014</xref>; Ruggeri et al. <xref ref-type="bibr" rid="CR230">2014</xref>; Georgiades et al. <xref ref-type="bibr" rid="CR77">2013</xref>). However, in spite of these issues those who believe that adjuvants cause “autism” have one question which currently remains unanswered, namely that if aluminium or other adjuvants <italic>per se</italic> provoke chronic central nervous system and peripheral pathology, why is the prevalence of ASD not far higher than it is now? Given the ubiquity of vaccination one would expect that almost every child would be affected. This fact alone means that adjuvants are highly unlikely to be the main cause of ASD. However, research within the ASIA paradigm and beyond does suggest that aluminium adjuvants, and indeed vaccination <italic>per se</italic>, can cause serious long-term pathology in people with a certain genetic vulnerability, especially in the case of latent or subclinical auto-immune diseases, and we now move on briefly to detail such evidence.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Section 2. Pathological effects of vaccines in people with a predisposition to autoimmunity</title>
<p id="Par23">Langer-Gould and colleagues reviewed the medical records of 780 patients with newly diagnosed MS, clinically isolated syndrome (optic neuritis, transverse myelitis, and monofocal or multifocal clinically isolated syndrome) or acute disseminated encephalomyelitis (ADEM) and concluded that vaccines may accelerate or precipitate the transition between subclinical and overt symptomatic autoimmune conditions within the first 30 days post-immunisation, particularly in those aged under 50 years (Langer-Gould et al. <xref ref-type="bibr" rid="CR139">2014</xref>). Several other authors have reported an association between the quadrivalent human papilloma vaccine and the development of several autoimmune diseases including Raynaud’s disease, Behçet’s syndrome, type 1 diabetes mellitus and Hashimoto’s syndrome (Arnheim-Dahlstrom et al. <xref ref-type="bibr" rid="CR15">2013</xref>; Chao et al. <xref ref-type="bibr" rid="CR38">2012</xref>). However, once again it would appear that affected patients displayed signs of subclinical autoimmunity prior to vaccination which may have subsequently triggered active disease (Chao et al. <xref ref-type="bibr" rid="CR38">2012</xref>; Arnheim-Dahlstrom et al. <xref ref-type="bibr" rid="CR15">2013</xref>). Many research teams reviewing adverse event data have reached similar conclusions (Pellegrino et al. <xref ref-type="bibr" rid="CR205">2015</xref>; Petrovsky <xref ref-type="bibr" rid="CR211">2015</xref>; Guimaraes et al. <xref ref-type="bibr" rid="CR86">2015</xref>). Grimaldi-Bensouda and colleagues found a positive association between a personal and family history of autoimmune diseases and the development of several different autoimmune diseases post-vaccination (Grimaldi-Bensouda et al. <xref ref-type="bibr" rid="CR84">2014</xref>). Interestingly, and perhaps reassuringly, a prospective longitudinal case-controlled study examining initially unaffected patients with no evidence of overt or covert autoimmune disease failed to demonstrate any association between vaccination and the development of ADEM or other autoimmune conditions (Scheller et al. <xref ref-type="bibr" rid="CR234">2015</xref>). However, as previously noted, there is considerable evidence that vaccines, or more likely vaccine adjuvants, may precipitate specific autoimmune sequelae in genetically or epigenetically vulnerable people (Pellegrino et al. <xref ref-type="bibr" rid="CR205">2015</xref>; Petrovsky <xref ref-type="bibr" rid="CR211">2015</xref>; Guimaraes et al. <xref ref-type="bibr" rid="CR86">2015</xref>). We will now discuss possible mechanisms which may underpin this effect.</p>
<sec id="Sec7">
<title>Polymorphisms in human leukocyte antigen (HLA) and Toll-like receptor (TLR) and immune response to vaccination</title>
<p id="Par24">There is a vast body of data demonstrating that immune and inflammatory responses to vaccines such as MMR are heavily influenced by polymorphisms in the HLA region and in genes encoding effector proteins such as cytokines and PRRs which have the capacity to recognise and become activated by conserved pathogen-associated molecular patterns (PAMPs) to produce immune response molecules such as PICs and interferons (Haralambieva et al. <xref ref-type="bibr" rid="CR91">2013</xref>; Lucas and Maes <xref ref-type="bibr" rid="CR151">2013</xref>). Examples of PRRs include membrane-bound receptors such as TLRs (e.g. TLR-4) and cytosolic receptors such as retinoic acid-inducible gene (RIG)-like receptors (Kumar et al. <xref ref-type="bibr" rid="CR133">2013</xref>). Readers interested in examining the evidence purporting to demonstrate an association between HLA polymorphisms and unusual response to the MMR vaccine are referred to an excellent review by Castiblanco and Anaya <xref ref-type="bibr" rid="CR35">2015</xref>. Extensive research has also revealed that immune responses to vaccines <italic>per se</italic> in any given individual are determined by polymorphisms and methylation patterns in the HLA region, cytokine and TLR genes coupled with the composition of the microbiome, the presence of co-infections, and a whole host of environmental variables (review Poland et al. <xref ref-type="bibr" rid="CR215">2013</xref>). These observations provide the basis for a mechanism whereby adjuvants could provoke an abnormal response in people with certain polymorphisms and/or methylation patterns in the HLA region, cytokine and TLR genes leading to excessively powerful and/or prolonged immune activity resulting in tissue damage and the generation of DAMPs, such as S100b, with the subsequent development of chronic immune and inflammatory pathology (Lucas and Maes <xref ref-type="bibr" rid="CR151">2013</xref>; Lucas et al. <xref ref-type="bibr" rid="CR152">2015</xref>). This will be the theme developed in the remainder of this paper. First, however, it is appropriate to consider whether aluminium in environmental or adjuvant form does indeed possess the capacity to generate the range of pathology seen in some children with an ASD diagnosis, which we will now consider.</p>
</sec>
</sec>
<sec id="Sec8">
<title>Section 3. Chronic aluminium exposure and the development of chronic oxidative stress, mitochondrial dysfunction and gliopathology</title>
<sec id="Sec9">
<title>Aluminium exposure provoking PIC and chemokine production</title>
<p id="Par25">Aluminium salt-containing adjuvants induce the production of the interleukins (ILs) IL-1β, IL-8 and IL-18 in TLR-stimulated dendritic cells and macrophages (Kuroda et al. <xref ref-type="bibr" rid="CR134">2011</xref>; Li et al. <xref ref-type="bibr" rid="CR145">2008</xref>; Sharp et al. <xref ref-type="bibr" rid="CR237">2009</xref>). There are now considerable, albeit <italic>in vitro</italic>, data demonstrating that such activation is dependent upon nucleotide-binding oligomerisation domain-like receptor pyrin domain-3 (NLRP3) inflammasome activation (Kool et al. <xref ref-type="bibr" rid="CR124">2008a</xref>; Franchi and Nunez <xref ref-type="bibr" rid="CR71">2008</xref>). Aluminium salts can activate the NLRP3 inflammasome via a number of different routes. These include destabilisation of phagosomes, acidification of lysosomes and increases in reactive oxygen species (ROS) levels (Kool et al. <xref ref-type="bibr" rid="CR127">2012</xref>; Hornung et al. <xref ref-type="bibr" rid="CR101">2008</xref>; Sharp et al. <xref ref-type="bibr" rid="CR237">2009</xref>). <italic>In vivo</italic>, aluminium hydroxide appears to induce dendritic cell and T-cell activation at least partly via NLRP3 activation (Kool et al. <xref ref-type="bibr" rid="CR124">2008a</xref>; Eisenbarth et al. <xref ref-type="bibr" rid="CR55">2008</xref>) although alternative routes such as immunoreceptor tyrosine-based activation motif (ITAM) and interferon response factor 3 (irf3) activation appear to be involved (Kuroda et al. <xref ref-type="bibr" rid="CR134">2011</xref>; Marichal et al. <xref ref-type="bibr" rid="CR162">2011</xref>). Aluminium adjuvants also provoke an immune response via the generation of DAMPs, notably uric acid and host DNA (outside cell nuclei and mitochondria) (Kool et al. <xref ref-type="bibr" rid="CR127">2012</xref>; Kool et al. <xref ref-type="bibr" rid="CR125">2008b</xref>). There is a body of evidence demonstrating that uric acid and DNA are released <italic>in vivo</italic> following aluminium hydroxide injection (Marichal et al. <xref ref-type="bibr" rid="CR162">2011</xref>; Kool et al. <xref ref-type="bibr" rid="CR125">2008b</xref>). Uric acid is a DAMP synthesised during purine nucleotide catabolism whose concentration increases during cellular stress, such as at the site of injection (Kool et al. <xref ref-type="bibr" rid="CR125">2008b</xref>). The functional relevance of uric acid levels in increasing T-cell priming and the instigation of humoral immune responses has been repeatedly demonstrated (Kool et al. <xref ref-type="bibr" rid="CR125">2008b</xref>; Munks et al. <xref ref-type="bibr" rid="CR188">2010</xref>). Both uric acid and aluminium hydroxide can independently activate the NLRP3 inflammasome, inducing the secretion of IL-1β (Kool et al. <xref ref-type="bibr" rid="CR124">2008a</xref>; Franchi and Nunez <xref ref-type="bibr" rid="CR71">2008</xref>). Uric acid crystals administered in the form of an adjuvant can also induce complement responses and a T helper type 2 (T<sub>h</sub>2) cell differentiation pattern (Kool et al. <xref ref-type="bibr" rid="CR126">2011</xref>; Shi et al. <xref ref-type="bibr" rid="CR240">2003</xref>). Host DNA released into the intracellular space following cellular necrosis also acts as a DAMP. Testimony to the highly immunogenic nature of double-stranded stranded DNA is shown by data demonstrating that it can be used as a substitute for aluminium hydroxide as a vaccine adjuvant (Marichal et al. <xref ref-type="bibr" rid="CR162">2011</xref>). Double-stranded cytosolic DNA is sensed by a number of PRRs including TLR-9, leading to the production of PICs via the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) or interferon-beta (IFN-β) via the activation of irf3 (Stetson and Medzhitov <xref ref-type="bibr" rid="CR248">2006</xref>; Thompson et al. <xref ref-type="bibr" rid="CR259">2011</xref>).</p>
</sec>
<sec id="Sec10">
<title>Aluminium exposure and the generation of oxidative stress</title>
<p id="Par26">Oxidative damage as evidenced by increased lipid peroxidation and depleted anti-oxidant defences induced by prolonged aluminium exposure appears to be focused in the prefrontal cortex, cerebellum, hippocampus and brainstem (Yuan et al. <xref ref-type="bibr" rid="CR284">2012</xref>; Kumar et al. <xref ref-type="bibr" rid="CR132">2011</xref>). It is also noteworthy that several authors have reported a linear relationship between increased cellular levels of aluminium and concentrations of protein carbonyls and S100 proteins (Mannello et al. <xref ref-type="bibr" rid="CR161">2013</xref>; Darbre et al. <xref ref-type="bibr" rid="CR46">2013</xref>; Darbre et al. <xref ref-type="bibr" rid="CR45">2011</xref>). This is of particular interest as these molecules may function as DAMPs and cause chronic stimulation of PRRs and hence be a source of chronic immune activation as discussed above. Increased levels of lipid peroxidation in the brain with the production of malondialdehyde (MDA), 4-hydroxy-2-<italic>trans</italic>-nonenal (HNE or 4-hydroxynonenal (4-HNA)) and thiobarbituric acid-reactive substances (TBARS) following oral administration of aluminium chloride is also a common finding in small-animal studies (Newairy et al. <xref ref-type="bibr" rid="CR197">2009</xref>; Albendea et al. <xref ref-type="bibr" rid="CR8">2007</xref>; Yuan et al. <xref ref-type="bibr" rid="CR284">2012</xref>; Lu et al. <xref ref-type="bibr" rid="CR149">2013</xref>).</p>
<p id="Par27">Chronic aluminium exposure also exerts profound detrimental effects on cellular anti-oxidant defences leading to significantly reduced cellular levels of glutathione transferase, glutathione peroxidase, catalase, superoxide dismutase and reduced glutathione (GSH) (Nampoothiri et al. <xref ref-type="bibr" rid="CR192">2015</xref>; El-Demerdash <xref ref-type="bibr" rid="CR57">2004</xref>; Yousef <xref ref-type="bibr" rid="CR283">2004</xref>; Kumar et al. <xref ref-type="bibr" rid="CR132">2011</xref>; Newairy et al. <xref ref-type="bibr" rid="CR197">2009</xref>). Aluminium ingestion also decreases GSH levels in human blood samples (Khan et al. <xref ref-type="bibr" rid="CR116">2011</xref>). Interestingly, aluminium decreases levels of this thiol by inhibiting the activity of NADPH-dependent isocitrate dehydrogenase in mitochondria and malic enzyme and NADPH isocitrate dehydrogenase in the cytosol (Murakami and Yoshino <xref ref-type="bibr" rid="CR189">2004</xref>). This is of importance as depleted levels of these enzymes make cells more sensitive to lipid peroxidation and oxidative mitochondrial DNA damage from singlet oxygen species in an environment of chronic oxidative stress (Kim and Park <xref ref-type="bibr" rid="CR117">2003</xref>; Lee et al. <xref ref-type="bibr" rid="CR141">2002</xref>; Kochevar <xref ref-type="bibr" rid="CR122">2004</xref>). In this context the existence of oxidative damage to mitochondrial proteins and DNA following prolonged aluminium exposure was reported by Sharma and colleagues (Sharma et al. <xref ref-type="bibr" rid="CR236">2013</xref>). Aluminium ingestion also leads to increased oxidative stress, markers of lipid peroxidation and decreased GSH levels in the epithelial cells lining the small intestine (Orihuela et al. <xref ref-type="bibr" rid="CR199">2005</xref>). This depletion of GSH appears to be affected by reduced activity of GSH synthase, GSH reductase and as yet undelineated changes to the plasma membranes resulting in a reduced influx of GSH from the lumen to the mucosa (Orihuela et al. <xref ref-type="bibr" rid="CR199">2005</xref>). This aluminium-induced depletion of GSH impairs the activity of calbindin-D9k resulting in decreased transcellular absorption of calcium ions (Orihuela et al. <xref ref-type="bibr" rid="CR199">2005</xref>). Given the positive role played by calcium ions in maintaining epithelial barrier integrity (Ma et al. <xref ref-type="bibr" rid="CR155">2000</xref>; Schepens et al. <xref ref-type="bibr" rid="CR235">2009</xref>), depletion of GSH could well underpin the increases in intestinal inflammation and intestinal barrier permeability caused by prolonged consumption of aluminium (Pineton de Chambrun et al. <xref ref-type="bibr" rid="CR213">2014</xref>).</p>
</sec>
<sec id="Sec11">
<title>Aluminium exposure and the development of mitochondrial dysfunction</title>
<p id="Par28">Oxidative stress and subsequent mitochondrial dysfunction constitute the major vehicle underpinning aluminium-induced neurotoxicity (for review see Kumar and Gill <xref ref-type="bibr" rid="CR130">2014</xref>). Exposure to aluminium ions leads to a significant decrease in the activity of cytochrome C oxidase, NADH and succinate dehydrogenase, and a subsequent decrease in state 3 (ADP stimulated) and state 4 mitochondrial respiration, which are likely caused by conformational changes in these enzymes as a direct result of aluminium ion binding (Dua et al. <xref ref-type="bibr" rid="CR52">2010</xref>; Mohan et al. <xref ref-type="bibr" rid="CR174">2009</xref>; Mustafa Rizvi et al. <xref ref-type="bibr" rid="CR190">2014</xref>; Kumar et al. <xref ref-type="bibr" rid="CR131">2008</xref>). Aluminium also impairs mitochondrial biogenesis by decreasing levels of peroxisome proliferator activated receptor gamma co-activator 1α (PGC-1α) activity, either directly or indirectly as a result of inducing elevated levels of oxidative stress (Sharma et al. <xref ref-type="bibr" rid="CR236">2013</xref>). Aluminium ions also display the capacity to bind to the phosphate groups of ATP and ADP and inhibit the phosphorylation of the latter molecule and the dephosphorylation of the former, and this together with the capacity to inhibit a wide range of kinase and phosphatase enzymes can grossly impair energy homeostasis (Kawahara and Kato-Negishi <xref ref-type="bibr" rid="CR113">2011</xref>).</p>
<p id="Par29">Aluminium can also impair mitochondrial function indirectly via mechanisms such as the induction of endoplasmic reticulum (ER) stress (Mustafa Rizvi et al. <xref ref-type="bibr" rid="CR190">2014</xref>; Johnson et al. <xref ref-type="bibr" rid="CR109">2005</xref>). Aluminium also induces mitochondrial dysfunction by provoking release of calcium ions from intracellular stores, and it is noteworthy that aluminium-induced oxidative damage and disruption of calcium ion homeostasis is similar in pattern to that seen in AD (Johnson et al. <xref ref-type="bibr" rid="CR109">2005</xref>; Walton <xref ref-type="bibr" rid="CR273">2012</xref>). The functional and physical relationship between the ER and mitochondria is well documented in the context of apoptosis, but perhaps under-discussed in the context of ER stress which is sub-lethal to the cell (Vannuvel et al. <xref ref-type="bibr" rid="CR265">2013</xref>). In the latter environment, the unfolded protein response in general, and protein kinase RNA-like ER kinase activity in particular, leads to a state of chronic mitochondrial underperformance rather than cellular death. This is a complex area and readers wishing to delve deeper into such mechanisms are invited to consult the work of Rainbolt et al. <xref ref-type="bibr" rid="CR221">2014</xref>.</p>
<p id="Par30">Calcium dyshomeostasis is equally detrimental to mitochondrial function and of vital importance in the maintenance of neural function by matching mitochondrial energy production to demand (Rueda et al. <xref ref-type="bibr" rid="CR229">2014</xref>; Llorente-Folch et al. <xref ref-type="bibr" rid="CR147">2013</xref>). In particular, modest elevations of calcium ions in the cytosol following increases in neural activity act as the “gas pedal” (or “accelerator”) to increase energy production and maintain ATP homeostasis, hence impaired calcium homeostasis can have profound adverse effects on neural function, even in the absence of frank apoptosis (Gellerich et al. <xref ref-type="bibr" rid="CR76">2013</xref>) The adverse effects of aluminium on calcium homeostasis is likely one mechanism involved in aluminium-induced neuropathology and we now turn to a consideration of other mechanisms whereby aluminium exposure could result in the type of astrocytic and microglial dysfunction seen in many children with a confirmed diagnosis of ASD.</p>
<p id="Par31">The above effects of aluminium are summarised in Fig. <xref ref-type="fig" rid="Fig1">1</xref>.</p>
</sec>
<sec id="Sec12">
<title>Aluminium exposure and glial cell activation or dysfunction</title>
<p id="Par32">Chronic or prolonged exposure to aluminium can induce astrocyte apoptosis with one mechanism thought to involve DNA and chromatin damage, and hence mediated by p53 (Suarez-Fernandez et al. <xref ref-type="bibr" rid="CR251">1999</xref>; Johnson et al. <xref ref-type="bibr" rid="CR109">2005</xref>). Another route may involve inhibition of mitochondrial function and ATP production, ultimately causing necrosis, which can have profound and prolonged neuro-inflammatory consequences (Lemire and Appanna <xref ref-type="bibr" rid="CR142">2011</xref>). Prolonged aluminium exposure can also induce significant metabolic changes in astrocytes, which can compromise function even in the absence of degeneration. Such abnormalities include decreasing the activity of γ-butyrobetainealdehyde dehydrogenase and γ-butyrobetainealdehyde dioxygenase and reduced levels of α-ketoglutarate (AKG), leading to low levels of L-carnitine and subsequently impaired fatty acid beta-oxidation, mitochondrial dysfunction, reduced ATP production and increased lipogenesis (Mailloux et al. <xref ref-type="bibr" rid="CR160">2011</xref>; Lemire et al. <xref ref-type="bibr" rid="CR143">2011</xref>; Han et al. <xref ref-type="bibr" rid="CR90">2013</xref>).</p>
<p id="Par33">The increased lipogenesis subsequent to aluminium-induced mitochondrial dysfunction via this route is enabled by significant increases in lipogenic enzymes such as acetyl CoA carboxylase (Mailloux et al. <xref ref-type="bibr" rid="CR157">2006</xref>). The increase in activity of these enzymes is accompanied by decreases in the activity of key enzymes within the electron transport chain and the tricarboxylic acid (Kreb’s) cycle, such as succinate dehydrogenase and AKG, leading to a significant decrease in the levels of ATP produced by oxidative phosphorylation (Mailloux et al. <xref ref-type="bibr" rid="CR159">2009</xref>; Mailloux et al. <xref ref-type="bibr" rid="CR157">2006</xref>; Mailloux et al. <xref ref-type="bibr" rid="CR158">2007</xref>). The loss of AKG activity in mitochondria and cytosol, likely caused by sequestration of this molecule by antioxidant defences, also results in significant negative consequences for energy generation within the glial cells. Briefly, AKG acts to stabilise hypoxia-inducible factor-1-alpha (HIF-1α) in the cytoplasm and prevents its translocation to the nucleus. However, in a cellular environment of increased aluminium cations and subsequently reduced AKG levels, HIF-1α translocates to the nucleus provoking increases in the transcription of hexokinase, pyruvate kinase, lactate dehydrogenase and glucose-6-phosphate dehydrogenase, with the ultimate effect of switching from energy production by oxidative phosphorylation to the phylogenetically more ancient pathway of energy production via glycolysis (Mailloux and Appanna <xref ref-type="bibr" rid="CR156">2007</xref>; Agrawal et al. <xref ref-type="bibr" rid="CR5">2007</xref>).</p>
<p id="Par34">Aluminium also induces significant alterations to glutamate/glutamine recycling within astrocytes leading to increased glutamine to glutamate conversion coupled with increased uptake of glutamate and increased intracellular levels of glutamine (Zielke et al. <xref ref-type="bibr" rid="CR294">1993</xref>; Struys-Ponsar et al. <xref ref-type="bibr" rid="CR249">2000</xref>). This has the effect of modulating glutamatergic and GABA-ergic neurotransmission, but may also have significant bioenergetic consequences given that increased levels of glutamate within astrocytes act as a further stimulus for increased glycolysis (Albrecht et al. <xref ref-type="bibr" rid="CR9">2010</xref>; Bouzier-Sore and Pellerin <xref ref-type="bibr" rid="CR32">2013</xref>). These observations are pertinent from the perspective of potentially impaired neurodevelopment as astrocytes play an important role in the development of the brain by regulating processes involved in synaptic transmission, neuronal migration, synaptogenesis and maybe even myelination (reviewed by Molofsky et al. <xref ref-type="bibr" rid="CR175">2012</xref>). The weight of evidence also indicates that the activity of these glial cells is of paramount importance in the development and maintenance of neural networks and circuits (Clarke and Barres <xref ref-type="bibr" rid="CR40">2013</xref>). Furthermore, there is now considerable evidence indicating that impaired astrocyte function plays a pivotal role in the pathogenesis of neurodevelopmental disorders (Molofsky et al. <xref ref-type="bibr" rid="CR175">2012</xref>; Sloan and Barres <xref ref-type="bibr" rid="CR245">2013</xref>; Yang et al. <xref ref-type="bibr" rid="CR280">2013</xref>).</p>
<p id="Par35">Aluminium can activate microglia leading to secretion of TNF-α, IL-6 and cytokine-inducible nitric oxide synthase (iNOS or NOS-2) and the development of neuro-inflammatory PICs and ROS (Bondy <xref ref-type="bibr" rid="CR29">2010</xref>; Zaky et al. <xref ref-type="bibr" rid="CR287">2013</xref>). This is also an important finding as there is now overwhelming evidence demonstrating that microglia play an indispensable role in the development of the brain by regulating processes such as synaptic pruning, synaptic plasticity, synaptogenesis, neuronal development and other vital processes in neurogenesis (Kettenmann et al. <xref ref-type="bibr" rid="CR115">2013</xref>). Microglial dysfunction and/or priming provoked by immune challenges, inflammatory events or other changes in the brain which interfere with processes such as synaptic pruning and neural proliferation is now thought to play a major causative role in the development of ASD and other neurodevelopmental disorders such a schizophrenia (Harry and Kraft <xref ref-type="bibr" rid="CR93">2012</xref>; Harry <xref ref-type="bibr" rid="CR92">2013</xref>; Hoeijmakers et al. <xref ref-type="bibr" rid="CR98">2016</xref>; Edmonson et al. <xref ref-type="bibr" rid="CR53">2016</xref>). The stepwise development of microglia is regulated by the activity of several genes, and disruption in the expression of these genes can occur as a result of prenatal immune activation or disturbances in the microbiota (Matcovitch-Natan et al. <xref ref-type="bibr" rid="CR166">2016</xref>). Aluminium can also provoke microglial activation and dysfunction via several other mechanisms, notably by impairing the function of the multifunctional molecular complex of the adapter protein, DNAX activating protein of 12 kD (DAP12) with TREM2, i.e. DAP12/TREM2, which is expressed on the surface of glial cells (Bhattacharjee et al. <xref ref-type="bibr" rid="CR25">2014</xref>; Zhao et al. <xref ref-type="bibr" rid="CR292">2014</xref>; Alexandrov et al. <xref ref-type="bibr" rid="CR10">2013</xref>).</p>
<p id="Par36">The DAP12/TREM2 protein complex plays a major role in the regulation of central nervous system homeostasis (Paradowska-Gorycka and Jurkowska <xref ref-type="bibr" rid="CR203">2013</xref>; Thrash et al. <xref ref-type="bibr" rid="CR260">2009</xref>). TREM2 binds a range of liposaccharides, phospholipids and polyanions with the subsequent activation of DAP12 and an array of downstream kinases cumulating in cellular activation (Poliani et al. <xref ref-type="bibr" rid="CR216">2015</xref>; Takahashi et al. <xref ref-type="bibr" rid="CR255">2007</xref>). Activation of the DAP12/TREM2 axis has an important role in limiting PICs and other neurotoxins following TLR activation by PAMPs and DAMPs, and promotes the survival and proliferation of microglia and other cells of the myeloid lineage (Poliani et al. <xref ref-type="bibr" rid="CR216">2015</xref>; Peng et al. <xref ref-type="bibr" rid="CR207">2013</xref>). However, in recent years the bulk of research on the DAP12/TREM2 complex has focused on its role in enabling and regulating microglial phagocytosis (Neumann and Takahashi <xref ref-type="bibr" rid="CR196">2007</xref>; Painter et al. <xref ref-type="bibr" rid="CR202">2015</xref>). TREM2 acts as a molecular sensor of macromolecular debris and plays an indispensable role in its immunogenically silent clearance, thereby resolving potentially inflammatory reactions and acting as an impediment to the development of neuro-inflammation (Painter et al. <xref ref-type="bibr" rid="CR202">2015</xref>; Takahashi et al. <xref ref-type="bibr" rid="CR254">2005</xref>; Takahashi et al. <xref ref-type="bibr" rid="CR255">2007</xref>; Hsieh et al. <xref ref-type="bibr" rid="CR102">2009</xref>).</p>
<p id="Par37">Microglial phagocytic processes play an essential role in removing damaged or stressed neurons and synaptic structures, apoptotic cells and other cellular debris from the brain, which have the potential of being immunogenic, and thus militate against the development of neuro-inflammation. Hence, this process plays an indispensable role in the maintenance of neural homeostasis (Fu et al. <xref ref-type="bibr" rid="CR74">2014</xref>; Jones et al. <xref ref-type="bibr" rid="CR110">2014</xref>; Zhao and Lukiw <xref ref-type="bibr" rid="CR290">2013</xref>). Unsurprisingly, several research teams have reported that failure of these unceasing microglial phagocytic processes have serious and potentially catastrophic innate-immune, pro-inflammatory and neuropathogenic consequences (Jones et al. <xref ref-type="bibr" rid="CR110">2014</xref>; Koenigsknecht-Talboo et al. <xref ref-type="bibr" rid="CR123">2008</xref>). Crucially, as previously noted, microglial apoptosis is both regulated and enabled by TREM2 (Zhao and Lukiw <xref ref-type="bibr" rid="CR290">2013</xref>; Alexandrov et al. <xref ref-type="bibr" rid="CR10">2013</xref>; Jones et al. <xref ref-type="bibr" rid="CR110">2014</xref>; Wang et al. <xref ref-type="bibr" rid="CR275">2015</xref>). Impairment in the activity and/or expression of TREM2 causes gross impairments of microglial phagocytic activity leading to a broad spectrum of central nervous system pathology including neuro-inflammation, synapatic loss, neuronal loss and exaggerated production of PICs (Wang et al. <xref ref-type="bibr" rid="CR275">2015</xref>; Hickman and El Khoury <xref ref-type="bibr" rid="CR97">2014</xref>; Jiang et al. <xref ref-type="bibr" rid="CR108">2014</xref>).</p>
<p id="Par38">TREM2 expression in turn is regulated by a number of miRNAs, most notably miR-34a (Zhao et al. <xref ref-type="bibr" rid="CR291">2013</xref>; Zhao and Lukiw <xref ref-type="bibr" rid="CR290">2013</xref>; Alexandrov et al. <xref ref-type="bibr" rid="CR10">2013</xref>). Microglial miR-34a expression is upregulated by activation of the pro-inflammatory transcription factor NF-κB (Zhang et al. <xref ref-type="bibr" rid="CR288">2011</xref>; Hickman and El Khoury <xref ref-type="bibr" rid="CR97">2014</xref>; Bhattacharjee et al. <xref ref-type="bibr" rid="CR25">2014</xref>). Aluminium in adjuvant or environmental form upregulates NF-κB (Pogue et al. <xref ref-type="bibr" rid="CR214">2009</xref>; Bondy <xref ref-type="bibr" rid="CR30">2014</xref>), and thereby induces a number of NF-κB-sensitive pro-inflammatory miRNAs, notably miR-34a (Fu et al. <xref ref-type="bibr" rid="CR74">2014</xref>; Jones et al. <xref ref-type="bibr" rid="CR110">2014</xref>; Hickman and El Khoury <xref ref-type="bibr" rid="CR97">2014</xref>; Zhang et al. <xref ref-type="bibr" rid="CR289">2013</xref>; Zhao and Lukiw <xref ref-type="bibr" rid="CR290">2013</xref>), which in turn downregulates TREM2 expression in the membranes of glial cells leading to a profound deficit in their phagocytic capability (Hickman and El Khoury <xref ref-type="bibr" rid="CR97">2014</xref>; Zhao et al. <xref ref-type="bibr" rid="CR291">2013</xref>; Bhattacharjee et al. <xref ref-type="bibr" rid="CR25">2014</xref>).</p>
<p id="Par39">Upregulation of NF-κB induces the synthesis of other inflammatory miRNAs such as miR-9, miR-125b, miR-146a and miR-155, which are recognised drivers of pathology in several neurodegenerative diseases such as AD (Zhao et al. <xref ref-type="bibr" rid="CR292">2014</xref>; Lukiw <xref ref-type="bibr" rid="CR153">2012</xref>). While aluminium clearly could provoke chronic pathology in people with a high or prolonged exposure, it should be further emphasised that the likelihood that adjuvant use could be the main cause of ASD in children, or indeed harmful to the vast majority of children with normal immune responses, appears to be vanishingly small. However, the situation in children with an abnormal immune system and a predisposition to autoimmunity may be different, and this will be the final area of discussion in this paper.</p>
<p id="Par40">The actions of aluminium on astrocytes and microglia are summarised in Fig. <xref ref-type="fig" rid="Fig2">2</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Summary of the effects of aluminium</p></caption><graphic id="MO1" xlink:href="11011_2017_77_Fig1_HTML"></graphic></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Effects of aluminium on astrocytes and microglia</p></caption><graphic id="MO2" xlink:href="11011_2017_77_Fig2_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec13">
<title>Section 4. Consequences of aluminium exposure in individuals with abnormal immune responses</title>
<sec id="Sec14">
<title>Polymorphisms in immune effector genes</title>
<p id="Par41">Abnormalities in the performance of PPRs are increasingly associated with the development of neurodegenerative and autoimmune conditions (Moraes et al. <xref ref-type="bibr" rid="CR177">2013</xref>; Cook et al. <xref ref-type="bibr" rid="CR41">2004</xref>; Marshak-Rothstein <xref ref-type="bibr" rid="CR165">2006</xref>; Pradhan et al. <xref ref-type="bibr" rid="CR219">2012</xref>; Liu et al. <xref ref-type="bibr" rid="CR146">2014</xref>). In particular, functional polymorphisms in the genes encoding proteins involved in effecting the immune response following ligation of TLR-4, TLR-7 and TLR-9 increase the susceptibility to and/or severity of a range of neurological, auto-immune, inflammatory and infective illnesses, including SLE, rheumatoid arthritis, asthma, sepsis and hepatitis (Moraes et al. <xref ref-type="bibr" rid="CR177">2013</xref>; Dhaouadi et al. <xref ref-type="bibr" rid="CR50">2013</xref>; Fichna et al. <xref ref-type="bibr" rid="CR67">2016</xref>; Netea et al. <xref ref-type="bibr" rid="CR195">2012</xref>). Unsurprisingly, functional polymorphisms in cytokine genes such as those encoding for TNF-α, IL-β, IL-6, IL-10 and IL-4 also increase the susceptibility to develop a range of inflammatory, infective and autoimmune conditions (Morris and Berk <xref ref-type="bibr" rid="CR180">2015</xref>).</p>
<p id="Par42">The presence of these polymorphisms can also heavily influence the severity and ultimate trajectory of these diseases in any given individual (Arfanakis et al. <xref ref-type="bibr" rid="CR14">2013</xref>; Tunçbilek <xref ref-type="bibr" rid="CR263">2014</xref>; Haukim et al. <xref ref-type="bibr" rid="CR94">2002</xref>; Hollegaard and Bidwell <xref ref-type="bibr" rid="CR99">2006</xref>). There is also accumulating evidence that functional polymorphisms in genes encoding cytokines and/or their receptors increase the risk of neuro-inflammatory and neurodegenerative pathology such as stroke, AD, and MS (Ottoboni et al. <xref ref-type="bibr" rid="CR201">2013</xref>; Bagnoli et al. <xref ref-type="bibr" rid="CR19">2007</xref>; Miranda-Hernandez and Baxter <xref ref-type="bibr" rid="CR172">2013</xref>; Cui et al. <xref ref-type="bibr" rid="CR43">2012</xref>). Functional polymorphisms can also lead to altered structure and function of receptor and effector proteins involved in a broad range of inflammasome responses, and once again such mutations are also involved in the pathogenesis of several autoimmune, neuro-immune and neurodegenerative diseases (Pontillo et al. <xref ref-type="bibr" rid="CR217">2012</xref>; Tan et al. <xref ref-type="bibr" rid="CR257">2013</xref>; review by Yang and Chiang <xref ref-type="bibr" rid="CR279">2015</xref>). In general, “pathological” polymorphisms within nuclear localisation leucine-rich-repeat protein-1 (NLRP1) pathways lead to an exaggerated and/or prolonged inflammatory response (Levandowski et al. <xref ref-type="bibr" rid="CR144">2013</xref>).</p>
<p id="Par43">It is of interest that recent research has revealed a significant association between the cumulative presence of immune gene polymorphisms and increased risk of developing ASD (Ramos et al. <xref ref-type="bibr" rid="CR222">2012</xref>). Single nucleotide polymorphisms (SNPs) in immune genes in many children also display a signature pattern which is characteristic of autoimmune diseases such as MS (Jung et al. <xref ref-type="bibr" rid="CR111">2011</xref>). Unsurprisingly, polymorphisms in the HLA system, notably HLA-DR4 and HLA-A2, are associated with a significantly increased likelihood of developing the syndrome (Mostafa et al. <xref ref-type="bibr" rid="CR186">2013</xref>; Torres et al. <xref ref-type="bibr" rid="CR262">2012</xref>). It is also noteworthy that the concomitant presence of abnormally expressed genes governing the regulation and delivery of immune and inflammatory responses can predict the development of ASD with some 83% accuracy (Pramparo et al. <xref ref-type="bibr" rid="CR220">2015</xref>).</p>
<p id="Par44">There is now copious evidence of dysregulated expression of genes regulating the innate and adaptive immune response in children with ASD (Michel et al. <xref ref-type="bibr" rid="CR171">2012</xref>; Gupta et al. <xref ref-type="bibr" rid="CR87">2014</xref>). There is also some evidence of functional polymorphisms coupled with exaggerated PRR responses in at least some affected children (Bennabi et al. <xref ref-type="bibr" rid="CR22">2015</xref>; Enstrom et al. <xref ref-type="bibr" rid="CR59">2010</xref>). There is also an accumulating body of research demonstrating that immune responses following activation of TLRs are abnormal in many children who have received a diagnosis of ASD (Mead and Ashwood <xref ref-type="bibr" rid="CR168">2015</xref>; Gesundheit et al. <xref ref-type="bibr" rid="CR78">2013</xref>; Enstrom et al. <xref ref-type="bibr" rid="CR59">2010</xref>). Moreover, several research teams have adduced evidence indicating that the immune response is abnormal in many children with ASD, and in particular that genes governing the regulation and performance of immune and inflammatory responses are upregulated allowing for an excessive and/or prolonged response to an environmental insult (Voineagu and Eapen <xref ref-type="bibr" rid="CR270">2013</xref>; Koufaris and Sismani <xref ref-type="bibr" rid="CR129">2015</xref>). It is also noteworthy that several researchers have also reported an association between initial inflammatory insults and the subsequent development of chronic immune disturbances in ASD children (Siniscalco <xref ref-type="bibr" rid="CR243">2015</xref>; Gottfried et al. <xref ref-type="bibr" rid="CR82">2015</xref>; McDougle et al. <xref ref-type="bibr" rid="CR167">2015</xref>). This is particularly noteworthy, as prolonged and/or excessive activation of immune and inflammatory pathways leading to oxidative and nitrosative stress can have detrimental consequences for cellular and tissue integrity, which in turn could lead to the chronic activation of immune and inflammatory pathways and ultimately of microglia and astrocytes in the brain as we will now discuss.</p>
</sec>
<sec id="Sec15">
<title>Prolonged or excessive immune responses and the production of DAMPs</title>
<p id="Par45">Oxidative stress activates NFκB and other transcription factors such as activated protein-1 (AP-1), leading to the synthesis and secretion of PICs, various chemokine species by antigen presentation cells, and activation and proliferation of T and B lymphocytes (Morris et al. <xref ref-type="bibr" rid="CR184">2015a</xref>; Lucas et al. <xref ref-type="bibr" rid="CR152">2015</xref>). Such activation and PIC production leads to the upregulation of iNOS and NADPH oxidase, leading to the production of superoxide, NO and peroxynitrite, and hence further increases in ROS and reactive nitrogen species (RNS) levels (Morris and Maes <xref ref-type="bibr" rid="CR183">2014</xref>; Morris et al. <xref ref-type="bibr" rid="CR184">2015a</xref>). This bidirectional and self-amplifying relationship between the development of chronic systemic inflammation as evidenced by increased PIC levels and chronic nitro-oxidative stress as evidenced by increased levels of ROS and RNS is often labelled an “autotoxic loop” (Reuter et al. <xref ref-type="bibr" rid="CR225">2010</xref>; Ortiz et al. <xref ref-type="bibr" rid="CR200">2013</xref>). Excessive levels of ROS and RNS can also lead to the oxidative and nitrosative modification of lipids, proteins and DNA, leading to misfolded, and consequently immunogenic, proteins, oxidative modification of DNA and lipid peroxidation of cell membranes, together with the production of highly reactive ketones and aldehydes (Lucas et al. <xref ref-type="bibr" rid="CR152">2015</xref>). The net result of these processes is the indirect and direct formation of DAMPs capable of activating pathogen-sensing receptors on the cell surface, and in the cytoplasm of immune cells (Hwang <xref ref-type="bibr" rid="CR103">2013</xref>; Ortiz et al. <xref ref-type="bibr" rid="CR200">2013</xref>).</p>
<p id="Par46">In summary, the presence of the immune abnormalities discussed allows for an abnormally excessive or prolonged inflammatory response following exposure to aluminium adjuvants, leading to the production of DAMPs and subsequent chronic immune activation in genetically susceptible children. It is noteworthy that several authors have reported the presence of DAMPs such as protein carbonyls, MDA and high-mobility group box-1 (HMGB1) protein in at least some children afforded a diagnosis of ASD, and such DAMPs could play a major role in initiating and maintaining a state of immune activation and inflammation seen in many children with an ASD diagnosis (Babinska et al. <xref ref-type="bibr" rid="CR17">2014</xref>; Emanuele et al. <xref ref-type="bibr" rid="CR58">2010</xref>; Frank et al. <xref ref-type="bibr" rid="CR72">2016</xref>; Napoli et al. <xref ref-type="bibr" rid="CR193">2013</xref>).</p>
<p id="Par47">Chronic engagement of TLRs by DAMPs leads to the development of a positive feedback loop, whereby increasing tissue damage caused by elevated PICs, ROS and RNS perpetuates and escalates pro-inflammatory responses, leading to a state of chronic inflammation nitro-oxidative stress, mitochondrial dysfunction and glial cell activation (Drexler and Foxwell <xref ref-type="bibr" rid="CR51">2010</xref>; Piccinini and Midwood <xref ref-type="bibr" rid="CR212">2010</xref>; Goh and Midwood <xref ref-type="bibr" rid="CR79">2012</xref>; Morris and Berk <xref ref-type="bibr" rid="CR180">2015</xref>). Unsurprisingly, chronic engagement of TLRs, nucleotide-binding oligomerisation domain (NOD)-like receptors and RIG-like receptors is implicated in the pathogenesis and pathophysiology of SLE, rheumatoid arthritis and MS (review (Drexler and Foxwell <xref ref-type="bibr" rid="CR51">2010</xref>; Piccinini and Midwood <xref ref-type="bibr" rid="CR212">2010</xref>; Goh and Midwood <xref ref-type="bibr" rid="CR79">2012</xref>)). Pertinently, the presence of DAMPs can also lead to the chronic activation of the inflammasome (Anders and Schaefer <xref ref-type="bibr" rid="CR12">2014</xref>) which is also implicated in the development of neuro-inflammation and abnormal central nervous system signalling characteristic of neurodegenerative and neurodevelopmental disorders (Tan et al. <xref ref-type="bibr" rid="CR257">2013</xref>; Singhal et al. <xref ref-type="bibr" rid="CR242">2014</xref>). It is also of interest that a recent study has reported the presence of activated inflammasome complexes in at least some children afforded a diagnosis of ASD (Saresella et al. <xref ref-type="bibr" rid="CR233">2016</xref>) There is now overwhelming evidence that prolonged and/or chronic activation of peripheral immune and inflammatory pathways provokes the development of chronic neuro-inflammtion and/or microglial priming and a brief explanation of this process will constitute the final subsection of this paper.</p>
</sec>
<sec id="Sec16">
<title>Systemic immune activation primed microglia and chronic neuro-inflammation</title>
<p id="Par48">There is ample evidence demonstrating that chronic immune system activation and systemic inflammation can lead to the development of chronic neuro-inflammation (Perry and Holmes <xref ref-type="bibr" rid="CR209">2014</xref>; Cunningham <xref ref-type="bibr" rid="CR44">2013</xref>). Communication of inflammatory signals to the brain is mediated by PICs via a number of routes, including innervation of the vagus nerve, carrier-enabled transport across the blood-brain barrier (BBB), activation of endothelial cells within the BBB and perivascular macrophages, and finally via transport through circumventricular organs devoid of a functional BBB (Morris and Maes <xref ref-type="bibr" rid="CR182">2012</xref>, <xref ref-type="bibr" rid="CR183">2014</xref>). The transduced inflammatory signals may lead to the development of chronic neuro-inflammation via the activation of microglia if of sufficient intensity and/or duration or lead to the development of “primed” microglia (Perry and Holmes <xref ref-type="bibr" rid="CR209">2014</xref>; Su and Federoff <xref ref-type="bibr" rid="CR250">2014</xref>). Microglial priming involves the upregulation of a range of surface receptors such as MHC class II, CD11b and CD11c integrins, co-stimulatory molecule CD86 and TLR-4 (Su and Federoff <xref ref-type="bibr" rid="CR250">2014</xref>).</p>
<p id="Par49">Following the upregulation of these receptors, such microglia become exquisitely sensitive to subsequent inflammatory stimuli, leading to an exaggerated production of neurotoxic molecules that may exacerbate the pre-existing pathology and may even accelerate the progression of existing neuro-inflammatory or neurodegenerative diseases (Ferrari and Tarelli <xref ref-type="bibr" rid="CR66">2011</xref>; Lunnon et al. <xref ref-type="bibr" rid="CR154">2011</xref>). Activated microglia exert their neurotoxic effects by releasing PICs, such as TNF-α, IL-1β, IL-6, and IFN-γ, and free radicals including superoxide, NO and peroxynitrite, as well as inflammatory molecules such as prostaglandin E2. Moreover, TNF-α, IL-1β and IFN-γ can act as secondary sources of RNS and other inflammatory molecules by acting as potent inducers of iNOS and via their capacity to upregulate cyclooxygenase-2 (COX-2) with the resultant production of prostaglandin E2 (Morris et al. <xref ref-type="bibr" rid="CR185">2015b</xref>; Perry et al. <xref ref-type="bibr" rid="CR210">2010</xref>). The concept of microglial priming could change the frame of reference from a consideration of a single inoculation containing aluminium adjuvant to a cumulative effect caused by a vaccination schedule in which successive immune insults over a short period could provoke chronic pathology either directly, by provoking microglial activity, or more indirectly by provoking macromolecular damage which could eventually reach a threshold capable of provoking chronic pathology. It should be noted that there is an accumulating body of evidence, albeit from animal studies, that successive and frequent postnatal immune and inflammatory insults play a pivotal role in the advent of microglial priming and the genesis of neurodevelopmental disorders (Ibi and Yamada <xref ref-type="bibr" rid="CR104">2015</xref>; Nagai <xref ref-type="bibr" rid="CR191">2013</xref>). There is also emerging data implicating the development of microglial priming as a major factor in the development of several if not all neurodegenerative diseases (Bhattacharya et al. <xref ref-type="bibr" rid="CR26">2016</xref>; Zhao et al. <xref ref-type="bibr" rid="CR292">2014</xref>; Shastri et al. <xref ref-type="bibr" rid="CR238">2013</xref>; Hoeijmakers et al. <xref ref-type="bibr" rid="CR98">2016</xref>).</p>
</sec>
</sec>
<sec id="Sec17">
<title>Summary</title>
<p id="Par50">Evidence of the neurotoxicity of aluminium cations (Al<sup>3+</sup>) includes: an association between chronic aluminium exposure and the development of AD; the involvement of aluminium adjuvants in the development of ASIA; and epidemiological evidence pointing to an association between the use of aluminium adjuvants and ASD. There is good evidence to suggest that immunisation may accelerate or precipitate the transition between subclinical and overt symptomatic autoimmune conditions within the first 30 days post-immunisation, particularly in those younger than 50 years of age. The immune response to immunisation may be influenced by variations in HLA, TLR and cytokine genes. Moreover, aluminium exposure is associated with the production of pro-inflammatory cytokines and chemokines and with the development of chronic oxidative stress, mitochondrial dysfunction and glial activation or dysfunction; these changes in turn are associated with ASD.</p>
</sec>
<sec id="Sec18">
<title>Conclusions and Future Directions</title>
<p id="Par51">Aluminium has no known beneficial physiological action in the human body and some genetic polymorphisms predispose to a greater susceptibility to its adverse effects. Therefore, a strong case can be made for avoiding unnecessary exposure to environmental sources of aluminium salts, especially on the part of children, pregnant mothers and women of child-bearing age who may become pregnant. Such avoidance need not lead to hardship or inconvenience; aluminium cookware may be replaced by safer alternatives, while aluminium-containing antiperspirants, potentially implicated in the rise of cases of breast cancer particularly affecting the upper outer quadrant of the mammary gland, may be replaced by non-aluminium versions. The use of aluminium salts in medical products is a more contentious issue. While antacids are available which do not contain aluminium salts, the avoidance of immunisations which do not contain aluminium salts as adjuvants has wider political and financial implications. It would seem prudent to try to find an alternative to aluminium adjuvants as soon as possible and phase out their use.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors wish to thank Victoria Storey for her help in constructing the figures.</p>
</ack>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflicts of Interest</title>
<p id="Par52">The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdallah</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Hougaard</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Norgaard-Pedersen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bonefeld-Jorgensen</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Infections during pregnancy and after birth, and the risk of autism spectrum disorders: a register-based study utilizing a Danish historic birth cohort</article-title>
<source/>Turk psikiyatri dergisi = Turkish J Psychiatry
          <year>2012</year>
<volume>23</volume>
<issue>4</issue>
<fpage>229</fpage>
<lpage>235</lpage>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd-Elghaffar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>El-Sokkary</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Sharkawy</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Aluminum-induced neurotoxicity and oxidative damage in rabbits: protective effect of melatonin</article-title>
<source/>Neuro Endocrinol Lett
          <year>2005</year>
<volume>26</volume>
<issue>5</issue>
<fpage>609</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="pmid">16264393</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Israeli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Vaccines and autoimmunity</article-title>
<source/>Nat Rev Rheumatol
          <year>2009</year>
<volume>5</volume>
<issue>11</issue>
<fpage>648</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1038/nrrheum.2009.196</pub-id>
<pub-id pub-id-type="pmid">19865091</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zafrir</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kivity</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Balofsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Amital</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA)</article-title>
<source/>Immunol Res
          <year>2014</year>
<volume>60</volume>
<issue>2–3</issue>
<fpage>376</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="doi">10.1007/s12026-014-8604-2</pub-id>
<pub-id pub-id-type="pmid">25427994</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agrawal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guttapalli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Narayan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Risbud</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk</article-title>
<source/>Am J Physiol Cell Physiol
          <year>2007</year>
<volume>293</volume>
<issue>2</issue>
<fpage>C621</fpage>
<lpage>C631</lpage>
<pub-id pub-id-type="doi">10.1152/ajpcell.00538.2006</pub-id>
<pub-id pub-id-type="pmid">17442734</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Santosh</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Metallomic profiling and linkage map analysis of early Parkinson's disease: a new insight to aluminum marker for the possible diagnosis</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<issue>6</issue>
<fpage>e11252</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0011252</pub-id>
<pub-id pub-id-type="pmid">20582167</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Ayadhi</surname>
<given-names>LY</given-names>
</name>
</person-group>
<article-title>Heavy metals and trace elements in hair samples of autistic children in central Saudi Arabia</article-title>
<source/>Neurosci (Riyadh, Saudi Arabia)
          <year>2005</year>
<volume>10</volume>
<issue>3</issue>
<fpage>213</fpage>
<lpage>218</lpage>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albendea</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Gomez-Trullen</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Fuentes-Broto</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Miana-Mena</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Millan-Plano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reyes-Gonzales</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Martinez-Ballarin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Melatonin reduces lipid and protein oxidative damage in synaptosomes due to aluminium</article-title>
<source/>J Trace Elements Med Biol: Organ of the Society for Minerals and Trace Elements (GMS)
          <year>2007</year>
<volume>21</volume>
<issue>4</issue>
<fpage>261</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.jtemb.2007.04.002</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albrecht</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sidoryk-Wegrzynowicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zielinska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aschner</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Roles of glutamine in neurotransmission</article-title>
<source/>Neuron Glia Biol
          <year>2010</year>
<volume>6</volume>
<issue>4</issue>
<fpage>263</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1017/S1740925X11000093</pub-id>
<pub-id pub-id-type="pmid">22018046</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexandrov</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line</article-title>
<source/>J Inorg Biochem
          <year>2013</year>
<volume>128</volume>
<fpage>267</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2013.05.010</pub-id>
<pub-id pub-id-type="pmid">23778113</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Olayan</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>El-Khadragy</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Abdel Moneim</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>The protective properties of melatonin against aluminium-induced neuronal injury</article-title>
<source/>Int J Exp Pathol
          <year>2015</year>
<volume>96</volume>
<issue>3</issue>
<fpage>196</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1111/iep.12122</pub-id>
<pub-id pub-id-type="pmid">25891353</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anders</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis</article-title>
<source/>J Am Soc Nephrol: JASN
          <year>2014</year>
<volume>25</volume>
<issue>7</issue>
<fpage>1387</fpage>
<lpage>1400</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2014010117</pub-id>
<pub-id pub-id-type="pmid">24762401</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stowe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association</article-title>
<source/>Pediatrics
          <year>2004</year>
<volume>114</volume>
<issue>3</issue>
<fpage>584</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2003-1177-L</pub-id>
<pub-id pub-id-type="pmid">15342825</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arfanakis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fleischman</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Grisot</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Varentsova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Systemic Inflammation in Non-Demented Elderly Human Subjects: Brain Microstructure and Cognition</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>8</issue>
<fpage>e73107</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0073107</pub-id>
<pub-id pub-id-type="pmid">23991174</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnheim-Dahlstrom</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pasternak</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Svanstrom</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sparen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hviid</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study</article-title>
<source/>BMJ
          <year>2013</year>
<volume>347</volume>
<fpage>f5906</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.f5906</pub-id>
<pub-id pub-id-type="pmid">24108159</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Assen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Elkayam</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cervera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Doran</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Dougados</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Emery</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Geborek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Jayne</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Kallenberg</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Muller-Ladner</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Stojanovich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Valesini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wulffraat</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Bijl</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases</article-title>
<source/>Autoimmun Rev
          <year>2011</year>
<volume>10</volume>
<issue>6</issue>
<fpage>341</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2010.12.003</pub-id>
<pub-id pub-id-type="pmid">21182987</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babinska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bucova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Durmanova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lakatosova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Janosikova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bakos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hlavata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ostatnikova</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Increased plasma levels of the high mobility group box 1 protein (HMGB1) are associated with a higher score of gastrointestinal dysfunction in individuals with autism</article-title>
<source/>Physiol Res
          <year>2014</year>
<volume>63</volume>
<issue>Suppl 4</issue>
<fpage>S613</fpage>
<lpage>S618</lpage>
<pub-id pub-id-type="pmid">25669692</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagavant</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nandula</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Kaplonek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rybakowska</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Deshmukh</surname>
<given-names>US</given-names>
</name>
</person-group>
<article-title>Alum, an Aluminum Based Adjuvant, Induces Sjögren’s Syndrome-like Disorder in Mice</article-title>
<source/>Clin Exp Rheumatol
          <year>2014</year>
<volume>32</volume>
<issue>2</issue>
<fpage>251</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="pmid">24739520</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagnoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cellini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tedde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nacmias</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bessi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bracco</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sorbi</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Association of IL10 promoter polymorphism in Italian Alzheimer's disease</article-title>
<source/>Neurosci Lett
          <year>2007</year>
<volume>418</volume>
<issue>3</issue>
<fpage>262</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2007.03.030</pub-id>
<pub-id pub-id-type="pmid">17420099</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Forssell</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Wetterberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Winblad</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease</article-title>
<source/>J Neural Transm Park Dis Dement Sect
          <year>1991</year>
<volume>3</volume>
<issue>4</issue>
<fpage>231</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="pmid">1772577</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beauchemin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kisilevsky</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques</article-title>
<source/>Anal Chem
          <year>1998</year>
<volume>70</volume>
<issue>5</issue>
<fpage>1026</fpage>
<lpage>1029</lpage>
<pub-id pub-id-type="doi">10.1021/ac970783f</pub-id>
<pub-id pub-id-type="pmid">9511476</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennabi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fortier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lajnef</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boukouaci</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Feugeas</surname>
<given-names>J-P</given-names>
</name>
<name>
<surname>Marzais</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gaman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Charron</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ghaleh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Krishnamoorthy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tamouza</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>9</issue>
<fpage>e0137339</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0137339</pub-id>
<pub-id pub-id-type="pmid">26352598</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting</article-title>
<source/>Brain Res
          <year>2011</year>
<volume>1380</volume>
<fpage>42</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.078</pub-id>
<pub-id pub-id-type="pmid">21129364</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Culicchia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kruck</surname>
<given-names>TPA</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Pogue</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Selective accumulation of aluminum in cerebral arteries in Alzheimer's disease (AD)</article-title>
<source/>J Inorg Biochem
          <year>2013</year>
<volume>126</volume>
<fpage>35</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2013.05.007</pub-id>
<pub-id pub-id-type="pmid">23764827</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update</article-title>
<source/>Front Aging Neurosci
          <year>2014</year>
<volume>6</volume>
<fpage>116</fpage>
<pub-id pub-id-type="pmid">24987367</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Derecki</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Lovenberg</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Drevets</surname>
<given-names>WC</given-names>
</name>
</person-group>
<article-title>Role of neuro-immunological factors in the pathophysiology of mood disorders</article-title>
<source/>Psychopharmacology
          <year>2016</year>
<volume>233</volume>
<issue>9</issue>
<fpage>1623</fpage>
<lpage>1636</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-016-4214-0</pub-id>
<pub-id pub-id-type="pmid">26803500</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaurock-Busch</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>Rabah</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Heavy metals and trace elements in hair and urine of a sample of arab children with autistic spectrum disorder</article-title>
<source/>Maedica
          <year>2011</year>
<volume>6</volume>
<issue>4</issue>
<fpage>247</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">22879836</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaurock-Busch</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>Dessoki</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Rabah</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Toxic Metals and Essential Elements in Hair and Severity of Symptoms among Children with Autism</article-title>
<source/>Maedica
          <year>2012</year>
<volume>7</volume>
<issue>1</issue>
<fpage>38</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">23118818</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bondy</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>The neurotoxicity of environmental aluminum is still an issue</article-title>
<source/>Neurotoxicology
          <year>2010</year>
<volume>31</volume>
<issue>5</issue>
<fpage>575</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2010.05.009</pub-id>
<pub-id pub-id-type="pmid">20553758</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bondy</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration</article-title>
<source/>Toxicology
          <year>2014</year>
<volume>315</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2013.10.008</pub-id>
<pub-id pub-id-type="pmid">24189189</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouras</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Good</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Perl</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>A Laser Microprobe Mass Analysis of Brain Aluminum and Iron in Dementia pugilistica: Comparison with Alzheimer's Disease</article-title>
<source/>Eur Neurol
          <year>1997</year>
<volume>38</volume>
<issue>1</issue>
<fpage>53</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1159/000112903</pub-id>
<pub-id pub-id-type="pmid">9252800</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<mixed-citation publication-type="other">Bouzier-Sore A-K, Pellerin L (2013) Unraveling the complex metabolic nature of astrocytes. Front Cell Neurosci 7. doi:10.3389/fncel.2013.00179</mixed-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bushnell</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Special issue: Environmental influences and emerging mechanisms in the etiology of autism</article-title>
<source/>Neurotoxicol Teratol
          <year>2013</year>
<volume>36</volume>
<fpage>1</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="doi">10.1016/j.ntt.2013.03.001</pub-id>
<pub-id pub-id-type="pmid">23531343</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Careaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders: from immunity to behavior</article-title>
<source/>Methods Mol Biol
          <year>2012</year>
<volume>934</volume>
<fpage>219</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-62703-071-7_12</pub-id>
<pub-id pub-id-type="pmid">22933149</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castiblanco</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anaya</surname>
<given-names>J-M</given-names>
</name>
</person-group>
<article-title>Genetics and Vaccines in the Era of Personalized Medicine</article-title>
<source/>Current Genomics
          <year>2015</year>
<volume>16</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.2174/1389202916666141223220551</pub-id>
<pub-id pub-id-type="pmid">25937813</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerpa-Cruz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Paredes-Casillas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Landeros Navarro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bernard-Medina</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Martinez-Bonilla</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gutierrez-Urena</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Adverse events following immunization with vaccines containing adjuvants</article-title>
<source/>Immunol Res
          <year>2013</year>
<volume>56</volume>
<issue>2–3</issue>
<fpage>299</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="doi">10.1007/s12026-013-8400-4</pub-id>
<pub-id pub-id-type="pmid">23576057</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chafi</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Hauw</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Rancurel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Galle</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Absence of aluminium in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies</article-title>
<source/>Neurosci Lett
          <year>1991</year>
<volume>123</volume>
<issue>1</issue>
<fpage>61</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(91)90158-P</pub-id>
<pub-id pub-id-type="pmid">1829512</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Velicer</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Sy</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Slezak</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Takhar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ackerson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cheetham</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deosaransingh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Emery</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liaw</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine</article-title>
<source/>J Intern Med
          <year>2012</year>
<volume>271</volume>
<issue>2</issue>
<fpage>193</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2796.2011.02467.x</pub-id>
<pub-id pub-id-type="pmid">21973261</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Elevated mitochondrial DNA copy number in peripheral blood cells is associated with childhood autism</article-title>
<source/>BMC Psychi
          <year>2015</year>
<volume>15</volume>
<fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/s12888-015-0432-y</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Emerging roles of astrocytes in neural circuit development</article-title>
<source/>Nat Rev Neurosci
          <year>2013</year>
<volume>14</volume>
<issue>5</issue>
<fpage>311</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3484</pub-id>
<pub-id pub-id-type="pmid">23595014</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Pisetsky</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Toll-like receptors in the pathogenesis of human disease</article-title>
<source/>Nat Immunol
          <year>2004</year>
<volume>5</volume>
<issue>10</issue>
<fpage>975</fpage>
<lpage>979</lpage>
<pub-id pub-id-type="doi">10.1038/ni1116</pub-id>
<pub-id pub-id-type="pmid">15454920</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cruz-Tapias</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Israeli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Anaya</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)--animal models as a proof of concept</article-title>
<source/>Current Med Chem
          <year>2013</year>
<volume>20</volume>
<issue>32</issue>
<fpage>4030</fpage>
<lpage>4036</lpage>
<pub-id pub-id-type="doi">10.2174/09298673113209990253</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke</article-title>
<source/>J Neuroinflammation
          <year>2012</year>
<volume>9</volume>
<fpage>235</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-9-235</pub-id>
<pub-id pub-id-type="pmid">23050663</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunningham</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Microglia and neurodegeneration: the role of systemic inflammation</article-title>
<source/>Glia
          <year>2013</year>
<volume>61</volume>
<fpage>71</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22350</pub-id>
<pub-id pub-id-type="pmid">22674585</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Pugazhendhi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mannello</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Aluminium and human breast diseases</article-title>
<source/>J Inorg Biochem
          <year>2011</year>
<volume>105</volume>
<issue>11</issue>
<fpage>1484</fpage>
<lpage>1488</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2011.07.017</pub-id>
<pub-id pub-id-type="pmid">22099158</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Mannello</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Exley</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Aluminium and breast cancer: Sources of exposure, tissue measurements and mechanisms of toxicological actions on breast biology</article-title>
<source/>J Inorg Biochem
          <year>2013</year>
<volume>128</volume>
<fpage>257</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2013.07.005</pub-id>
<pub-id pub-id-type="pmid">23899626</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Sole</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chiarpotto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ciasca</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bocca</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Alimonti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bizzarro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Masullo</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Possible relationship between Al/ferritin complex and Alzheimer's disease</article-title>
<source/>Clin Biochem
          <year>2013</year>
<volume>46</volume>
<issue>1–2</issue>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2012.10.023</pub-id>
<pub-id pub-id-type="pmid">23103708</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Depino</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Peripheral and central inflammation in autism spectrum disorders</article-title>
<source/>Mol Cell Neurosci
          <year>2013</year>
<volume>53</volume>
<fpage>69</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2012.10.003</pub-id>
<pub-id pub-id-type="pmid">23069728</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeStefano</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Vaccines and autism: evidence does not support a causal association</article-title>
<source/>Clin Pharmacol Ther
          <year>2007</year>
<volume>82</volume>
<issue>6</issue>
<fpage>756</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="doi">10.1038/sj.clpt.6100407</pub-id>
<pub-id pub-id-type="pmid">17928818</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhaouadi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sfar</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Haouami</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Abdelmoula</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Turki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hassine</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Polymorphisms of Toll-like receptor-4 and CD14 in systemic lupus erythematosus and rheumatoid arthritis</article-title>
<source/>Biomark Res
          <year>2013</year>
<volume>1</volume>
<fpage>20</fpage>
<pub-id pub-id-type="doi">10.1186/2050-7771-1-20</pub-id>
<pub-id pub-id-type="pmid">24252506</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drexler</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Foxwell</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>The role of toll-like receptors in chronic inflammation</article-title>
<source/>Int J Biochem Cell Biol
          <year>2010</year>
<volume>42</volume>
<issue>4</issue>
<fpage>506</fpage>
<lpage>518</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2009.10.009</pub-id>
<pub-id pub-id-type="pmid">19837184</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dua</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sunkaria</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Impaired mitochondrial energy metabolism and kinetic properties of cytochrome oxidase following acute aluminium phosphide exposure in rat liver</article-title>
<source/>Food Chem Toxicol
          <year>2010</year>
<volume>48</volume>
<issue>1</issue>
<fpage>53</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2009.09.014</pub-id>
<pub-id pub-id-type="pmid">19766695</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmonson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Ziats</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Rennert</surname>
<given-names>OM</given-names>
</name>
</person-group>
<article-title>A Non-inflammatory Role for Microglia in Autism Spectrum Disorders</article-title>
<source/>Front Neurol
          <year>2016</year>
<volume>7</volume>
<fpage>9</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2016.00009</pub-id>
<pub-id pub-id-type="pmid">26869989</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwardson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Klinowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oakley</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Candy</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease</article-title>
<source/>CIBA Found Symp
          <year>1986</year>
<volume>121</volume>
<fpage>160</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">3743229</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenbarth</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Colegio</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>O'Connor</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sutterwala</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants</article-title>
<source/>Nature
          <year>2008</year>
<volume>453</volume>
<issue>7198</issue>
<fpage>1122</fpage>
<lpage>1126</lpage>
<pub-id pub-id-type="doi">10.1038/nature06939</pub-id>
<pub-id pub-id-type="pmid">18496530</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenkraft</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The role of glutamate and the immune system in organophosphate-induced CNS damage</article-title>
<source/>Neurotox Res
          <year>2013</year>
<volume>24</volume>
<issue>2</issue>
<fpage>265</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="doi">10.1007/s12640-013-9388-1</pub-id>
<pub-id pub-id-type="pmid">23532600</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Demerdash</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminium</article-title>
<source/>J Trace Elem Med Biol
          <year>2004</year>
<volume>18</volume>
<issue>1</issue>
<fpage>113</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1016/j.jtemb.2004.04.001</pub-id>
<pub-id pub-id-type="pmid">15487771</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emanuele</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boso</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brondino</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pietra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barale</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ucelli di Nemi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Politi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Increased serum levels of high mobility group box 1 protein in patients with autistic disorder</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <year>2010</year>
<volume>34</volume>
<issue>4</issue>
<fpage>681</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.03.020</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enstrom</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Onore</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Differential monocyte responses to TLR ligands in children with autism spectrum disorders</article-title>
<source/>Brain Behav Immun
          <year>2010</year>
<volume>24</volume>
<issue>1</issue>
<fpage>64</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2009.08.001</pub-id>
<pub-id pub-id-type="pmid">19666104</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prada</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mastrolia</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Tarantino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Codeca</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rigante</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background</article-title>
<source/>Immunol Res
          <year>2014</year>
<volume>60</volume>
<issue>2–3</issue>
<fpage>366</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1007/s12026-014-8586-0</pub-id>
<pub-id pub-id-type="pmid">25395340</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estes</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Immune mediators in the brain and peripheral tissues in autism spectrum disorder</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<issue>8</issue>
<fpage>469</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3978</pub-id>
<pub-id pub-id-type="pmid">26189694</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Exley</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The aluminium-amyloid cascade hypothesis and Alzheimer's disease</article-title>
<source/>Subcell Biochem
          <year>2005</year>
<volume>38</volume>
<fpage>225</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1007/0-387-23226-5_11</pub-id>
<pub-id pub-id-type="pmid">15709481</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Exley</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Esiri</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>2006</year>
<volume>77</volume>
<issue>7</issue>
<fpage>877</fpage>
<lpage>879</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2005.086553</pub-id>
<pub-id pub-id-type="pmid">16627535</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Exley</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vickers</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Elevated brain aluminium and early onset Alzheimer's disease in an individual occupationally exposed to aluminium: a case report</article-title>
<source/>J Med Case Rep
          <year>2014</year>
<volume>8</volume>
<issue>1</issue>
<fpage>41</fpage>
<pub-id pub-id-type="doi">10.1186/1752-1947-8-41</pub-id>
<pub-id pub-id-type="pmid">24513181</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Exley</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mamutse</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Korchazhkina</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Pye</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Strekopytov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Polwart</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Elevated urinary excretion of aluminium and iron in multiple sclerosis</article-title>
<source/>Mult Scler
          <year>2006</year>
<volume>12</volume>
<issue>5</issue>
<fpage>533</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1177/1352458506071323</pub-id>
<pub-id pub-id-type="pmid">17086897</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tarelli</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Parkinson's disease and systemic inflammation</article-title>
<source/>Parkinsons Dis
          <year>2011</year>
<volume>2011</volume>
<fpage>436813</fpage>
<pub-id pub-id-type="pmid">21403862</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fichna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zurawek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fichna</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Januszkiewicz-Lewandowska</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ruchala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nowak</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Polymorphisms of the Toll-Like Receptor-3 Gene in Autoimmune Adrenal Failure and Type 1 Diabetes in Polish Patients</article-title>
<source/>Arch Immunol Ther Exp
          <year>2016</year>
<volume>64</volume>
<issue>1</issue>
<fpage>83</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1007/s00005-015-0360-z</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fido</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Saad</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Toxic trace elements in the hair of children with autism</article-title>
<source/>Autism
          <year>2005</year>
<volume>9</volume>
<issue>3</issue>
<fpage>290</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1177/1362361305053255</pub-id>
<pub-id pub-id-type="pmid">15937043</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flashner</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Boileau</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Gallicano</surname>
<given-names>GI</given-names>
</name>
</person-group>
<article-title>Epigenetic factors and autism spectrum disorders</article-title>
<source/>NeuroMolecular Med
          <year>2013</year>
<volume>15</volume>
<issue>2</issue>
<fpage>339</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1007/s12017-013-8222-5</pub-id>
<pub-id pub-id-type="pmid">23468062</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flaten</surname>
<given-names>TP</given-names>
</name>
</person-group>
<article-title>Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water</article-title>
<source/>Brain Res Bull
          <year>2001</year>
<volume>55</volume>
<issue>2</issue>
<fpage>187</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1016/S0361-9230(01)00459-2</pub-id>
<pub-id pub-id-type="pmid">11470314</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franchi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nunez</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity</article-title>
<source/>Eur J Immunol
          <year>2008</year>
<volume>38</volume>
<issue>8</issue>
<fpage>2085</fpage>
<lpage>2089</lpage>
<pub-id pub-id-type="doi">10.1002/eji.200838549</pub-id>
<pub-id pub-id-type="pmid">18624356</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Fonken</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Hershman</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>SF</given-names>
</name>
</person-group>
<article-title>The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>55</volume>
<fpage>215</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2015.10.009</pub-id>
<pub-id pub-id-type="pmid">26482581</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frustaci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cesario</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Domenici</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dalla Bernardina</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Oxidative stress-related biomarkers in autism: systematic review and meta-analyses</article-title>
<source/>Free Radic Biol Med
          <year>2012</year>
<volume>52</volume>
<fpage>2128</fpage>
<lpage>2141</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.03.011</pub-id>
<pub-id pub-id-type="pmid">22542447</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Phagocytosis of microglia in the central nervous system diseases</article-title>
<source/>Mol Neurobiol
          <year>2014</year>
<volume>49</volume>
<issue>3</issue>
<fpage>1422</fpage>
<lpage>1434</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-013-8620-6</pub-id>
<pub-id pub-id-type="pmid">24395130</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulgenzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vietti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Aluminium Involvement in Neurotoxicity</article-title>
<source/>Biomed Res Int
          <year>2014</year>
<volume>2014</volume>
<fpage>758323</fpage>
<pub-id pub-id-type="pmid">25243176</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gellerich</surname>
<given-names>FN</given-names>
</name>
<name>
<surname>Gizatullina</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gainutdinov</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Muth</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seppet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Orynbayeva</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vielhaber</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The control of brain mitochondrial energization by cytosolic calcium: The mitochondrial gas pedal</article-title>
<source/>IUBMB Life
          <year>2013</year>
<volume>65</volume>
<issue>3</issue>
<fpage>180</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1002/iub.1131</pub-id>
<pub-id pub-id-type="pmid">23401251</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgiades</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Importance of studying heterogeneity in autism</article-title>
<source/>Neuropsychiatry
          <year>2013</year>
<volume>3</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.2217/npy.13.8</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gesundheit</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rosenzweig</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Naor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lerer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zachor</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Prochazka</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Melamed</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kristt</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Koren</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Walfisch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Passweg</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Snowden</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Tamouza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Farge-Bancel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Immunological and autoimmune considerations of Autism Spectrum Disorders</article-title>
<source/>J Autoimmun
          <year>2013</year>
<volume>44</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2013.05.005</pub-id>
<pub-id pub-id-type="pmid">23867105</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goh</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Midwood</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis</article-title>
<source/>Rheumatology (Oxford)
          <year>2012</year>
<volume>51</volume>
<issue>1</issue>
<fpage>7</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1093/rheumatology/ker257</pub-id>
<pub-id pub-id-type="pmid">21984766</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>DiMauro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: Evidence from brain imaging</article-title>
<source/>JAMA Psychiatry
          <year>2014</year>
<volume>71</volume>
<issue>6</issue>
<fpage>665</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.179</pub-id>
<pub-id pub-id-type="pmid">24718932</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Good</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Perl</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Bierer</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Schmeidler</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study</article-title>
<source/>Ann Neurol
          <year>1992</year>
<volume>31</volume>
<issue>3</issue>
<fpage>286</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410310310</pub-id>
<pub-id pub-id-type="pmid">1637136</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gottfried</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bambini-Junior</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Riesgo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Savino</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The Impact of Neuroimmune Alterations in Autism Spectrum Disorder</article-title>
<source/>Front Psychiatry
          <year>2015</year>
<volume>6</volume>
<fpage>121</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2015.00121</pub-id>
<pub-id pub-id-type="pmid">26441683</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grether</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Investigation of shifts in autism reporting in the California Department of Developmental Services</article-title>
<source/>J Autism Dev Disord
          <year>2009</year>
<volume>39</volume>
<issue>10</issue>
<fpage>1412</fpage>
<lpage>1419</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-009-0754-z</pub-id>
<pub-id pub-id-type="pmid">19479197</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimaldi-Bensouda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guillemot</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Godeau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Benichou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lebrun-Frenay</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Papeix</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Labauge</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Berquin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Penfornis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benhamou</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Nicolino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Viallard</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Costedoat-Chalumeau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Courcoux</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Pondarre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hilliquin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chatelus</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Foltz</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Guillaume</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abenhaim</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects</article-title>
<source/>J Intern Med
          <year>2014</year>
<volume>275</volume>
<issue>4</issue>
<fpage>398</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1111/joim.12155</pub-id>
<pub-id pub-id-type="pmid">24206418</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guevara-Campos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gonzalez-Guevara</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Puig-Alcaraz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cauli</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain</article-title>
<source/>Metab Brain Dis
          <year>2013</year>
<volume>28</volume>
<issue>4</issue>
<fpage>605</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1007/s11011-013-9419-x</pub-id>
<pub-id pub-id-type="pmid">23839164</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guimaraes</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Perricone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Vaccines, adjuvants and autoimmunity</article-title>
<source/>Pharmacol Res
          <year>2015</year>
<volume>100</volume>
<fpage>190</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2015.08.003</pub-id>
<pub-id pub-id-type="pmid">26275795</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<mixed-citation publication-type="other">Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS, Zhan J, West AB, Arking DE (2014) Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun 5. doi:10.1038/ncomms6748</mixed-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadjkacem</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ayadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Turki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yaich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khemekhem</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Walha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cherif</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Moalla</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ghribi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Prenatal, perinatal and postnatal factors associated with autism spectrum disorder</article-title>
<source/>J Pediatr
          <year>2016</year>
<volume>92</volume>
<issue>6</issue>
<fpage>595</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1016/j.jped.2016.01.012</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallmayer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GEnetic heritability and shared environmental factors among twin pairs with autism</article-title>
<source/>Arch Gen Psychiatry
          <year>2011</year>
<volume>68</volume>
<issue>11</issue>
<fpage>1095</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.76</pub-id>
<pub-id pub-id-type="pmid">21727249</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lemire</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Auger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Castonguay</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>How aluminum, an intracellular ROS generator promotes hepatic and neurological diseases: the metabolic tale</article-title>
<source/>Cell Biol Toxicol
          <year>2013</year>
<volume>29</volume>
<issue>2</issue>
<fpage>75</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1007/s10565-013-9239-0</pub-id>
<pub-id pub-id-type="pmid">23463459</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haralambieva</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Pankratz</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Poland</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches</article-title>
<source/>Exp Rev Vacc
          <year>2013</year>
<volume>12</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1586/erv.12.134</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harry</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Microglia during development and aging</article-title>
<source/>Pharmacol Ther
          <year>2013</year>
<volume>139</volume>
<issue>3</issue>
<fpage>313</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.04.013</pub-id>
<pub-id pub-id-type="pmid">23644076</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harry</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>Microglia in the developing brain: a potential target with lifetime effects</article-title>
<source/>Neurotoxicology
          <year>2012</year>
<volume>33</volume>
<issue>2</issue>
<fpage>191</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2012.01.012</pub-id>
<pub-id pub-id-type="pmid">22322212</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haukim</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bidwell</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AJP</given-names>
</name>
<name>
<surname>Keen</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kimberly</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huizinga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McDermott</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Oksenberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McNicholl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pociot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hardt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dalfonso</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Cytokine gene polymorphism in human disease: on-line databases, Supplement 2</article-title>
<source/>Genes Immun
          <year>2002</year>
<volume>3</volume>
<issue>6</issue>
<fpage>313</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1038/sj.gene.6363881</pub-id>
<pub-id pub-id-type="pmid">12209358</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders</article-title>
<source/>Curr Opin Neurol
          <year>2010</year>
<volume>23</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0b013e328336a01f</pub-id>
<pub-id pub-id-type="pmid">20087183</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Commentary: Diagnostic change and the increased prevalence of autism</article-title>
<source/>Int J Epidemiol
          <year>2009</year>
<volume>38</volume>
<issue>5</issue>
<fpage>1239</fpage>
<lpage>1241</lpage>
<pub-id pub-id-type="doi">10.1093/ije/dyp258</pub-id>
<pub-id pub-id-type="pmid">19737792</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hickman</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>El Khoury</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>TREM2 and the neuroimmunology of Alzheimer's disease</article-title>
<source/>Biochem Pharmacol
          <year>2014</year>
<volume>88</volume>
<issue>4</issue>
<fpage>495</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2013.11.021</pub-id>
<pub-id pub-id-type="pmid">24355566</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoeijmakers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heinen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>van Dam</surname>
<given-names>A-M</given-names>
</name>
<name>
<surname>Lucassen</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Korosi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microglial Priming and Alzheimer’s Disease: A Possible Role for (Early) Immune Challenges and Epigenetics?</article-title>
<source/>Front Hum Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>398</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2016.00398</pub-id>
<pub-id pub-id-type="pmid">27555812</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollegaard</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Bidwell</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Cytokine gene polymorphism in human disease: on-line databases, Supplement 3</article-title>
<source/>Genes Immun
          <year>2006</year>
<volume>7</volume>
<issue>4</issue>
<fpage>269</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1038/sj.gene.6364301</pub-id>
<pub-id pub-id-type="pmid">16642032</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooker</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Measles-mumps-rubella vaccination timing and autism among young african american boys: a reanalysis of CDC data</article-title>
<source/>Transl Neurodegener
          <year>2014</year>
<volume>3</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1186/2047-9158-3-1</pub-id>
<pub-id pub-id-type="pmid">24398160</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornung</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bauernfeind</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Halle</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Samstad</surname>
<given-names>EO</given-names>
</name>
<name>
<surname>Kono</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rock</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Latz</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization</article-title>
<source/>Nat Immunol
          <year>2008</year>
<volume>9</volume>
<issue>8</issue>
<fpage>847</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1631</pub-id>
<pub-id pub-id-type="pmid">18604214</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Spusta</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Niemi</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Yenari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Seaman</surname>
<given-names>WE</given-names>
</name>
</person-group>
<article-title>A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia</article-title>
<source/>J Neurochem
          <year>2009</year>
<volume>109</volume>
<issue>4</issue>
<fpage>1144</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06042.x</pub-id>
<pub-id pub-id-type="pmid">19302484</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Role of oxidative stress in Parkinson's disease</article-title>
<source/>Exp Neurobiol
          <year>2013</year>
<volume>22</volume>
<fpage>11</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.5607/en.2013.22.1.11</pub-id>
<pub-id pub-id-type="pmid">23585717</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation</article-title>
<source/>Int J Mol Sci
          <year>2015</year>
<volume>16</volume>
<issue>12</issue>
<fpage>28218</fpage>
<lpage>28229</lpage>
<pub-id pub-id-type="doi">10.3390/ijms161226092</pub-id>
<pub-id pub-id-type="pmid">26633355</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Israeli</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA)</article-title>
<source/>Lupus
          <year>2012</year>
<volume>21</volume>
<issue>2</issue>
<fpage>190</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1177/0961203311429552</pub-id>
<pub-id pub-id-type="pmid">22235052</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Duong</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Trapp</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Scheibel</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry</article-title>
<source/>Can J Neurol Sci
          <year>1989</year>
<volume>16</volume>
<fpage>498</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1017/S0317167100029838</pub-id>
<pub-id pub-id-type="pmid">2804812</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen-Jarolim</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Aluminium in Allergies and Allergen immunotherapy</article-title>
<source/>World Aller Org J
          <year>2015</year>
<volume>8</volume>
<issue>1</issue>
<fpage>7</fpage>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>QQ</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>LZ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YD</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease</article-title>
<source/>Neuropsychopharmacology
          <year>2014</year>
<volume>39</volume>
<issue>13</issue>
<fpage>2949</fpage>
<lpage>2962</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2014.164</pub-id>
<pub-id pub-id-type="pmid">25047746</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S-H</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Aluminum-Maltolate Induces Apoptosis and Necrosis in Neuro-2a Cells: Potential Role for p53 Signaling</article-title>
<source/>Toxicol Sci
          <year>2005</year>
<volume>83</volume>
<issue>2</issue>
<fpage>329</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfi028</pub-id>
<pub-id pub-id-type="pmid">15537749</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dua</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2)</article-title>
<source/>Front Cell Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>94</fpage>
<pub-id pub-id-type="pmid">24744699</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kohane</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Identification of autoimmune gene signatures in autism</article-title>
<source/>Transl Psychiatry
          <year>2011</year>
<volume>1</volume>
<fpage>e63</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2011.62</pub-id>
<pub-id pub-id-type="pmid">22832355</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawahara</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases</article-title>
<source/>J Alzheimer's Dis: JAD
          <year>2005</year>
<volume>8</volume>
<issue>2</issue>
<fpage>171</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2005-8210</pub-id>
<pub-id pub-id-type="pmid">16308486</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawahara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kato-Negishi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses</article-title>
<source/>Int J Alzheimers Dis
          <year>2011</year>
<volume>2011</volume>
<fpage>276393</fpage>
<pub-id pub-id-type="pmid">21423554</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kern</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Sykes</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Haley</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>The relationship between mercury and autism: A comprehensive review and discussion</article-title>
<source/>J Trace Elem Med Biol
          <year>2016</year>
<volume>37</volume>
<fpage>8</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.jtemb.2016.06.002</pub-id>
<pub-id pub-id-type="pmid">27473827</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kettenmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kirchhoff</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microglia: new roles for the synaptic stripper</article-title>
<source/>Neuron
          <year>2013</year>
<volume>77</volume>
<issue>1</issue>
<fpage>10</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.023</pub-id>
<pub-id pub-id-type="pmid">23312512</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Effect of aluminium metal on glutathione (GSH) level in plasma and cytosolic fraction of human blood</article-title>
<source/>Pak J Pharm Sci
          <year>2011</year>
<volume>24</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">21190912</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Cellular defense against singlet oxygen-induced oxidative damage by cytosolic NADP+−dependent isocitrate dehydrogenase</article-title>
<source/>Free Radic Res
          <year>2003</year>
<volume>37</volume>
<issue>3</issue>
<fpage>309</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1080/1071576021000050429</pub-id>
<pub-id pub-id-type="pmid">12688426</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Laska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Cheon</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Grinker</surname>
<given-names>RR</given-names>
</name>
</person-group>
<article-title>Prevalence of autism spectrum disorders in a total population sample</article-title>
<source/>Am J Psychiatry
          <year>2011</year>
<volume>168</volume>
<issue>9</issue>
<fpage>904</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101532</pub-id>
<pub-id pub-id-type="pmid">21558103</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bearman</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Diagnostic change and the increased prevalence of autism</article-title>
<source/>Int J Epidemiol
          <year>2009</year>
<volume>38</volume>
<issue>5</issue>
<fpage>1224</fpage>
<lpage>1234</lpage>
<pub-id pub-id-type="doi">10.1093/ije/dyp261</pub-id>
<pub-id pub-id-type="pmid">19737791</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Hus</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Moreno-De-Luca</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Grice</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mane</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Melhem</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Chaste</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Roeder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Common genetic variants, acting additively, are a major source of risk for autism</article-title>
<source/>Molecular Autism
          <year>2012</year>
<volume>3</volume>
<issue>1</issue>
<fpage>9</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-9</pub-id>
<pub-id pub-id-type="pmid">23067556</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lohmann</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Parkinson disease(s): Is “Parkin disease” a distinct clinical entity?</article-title>
<source/>Neurology
          <year>2009</year>
<volume>72</volume>
<issue>2</issue>
<fpage>106</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000333666.65522.8d</pub-id>
<pub-id pub-id-type="pmid">18987349</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<mixed-citation publication-type="other">Kochevar IE (2004) Singlet oxygen signaling: from intimate to global. Sci STKE 2004 (221):pe7. doi:10.1126/stke.2212004pe7</mixed-citation>
</ref>
<ref id="CR123">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koenigsknecht-Talboo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyer-Luehmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parsadanian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia-Alloza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Finn</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Bacskai</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Holtzman</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<issue>52</issue>
<fpage>14156</fpage>
<lpage>14164</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4147-08.2008</pub-id>
<pub-id pub-id-type="pmid">19109498</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kool</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Petrilli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De Smedt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rolaz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van Nimwegen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome</article-title>
<source/>J Immunol
          <year>2008</year>
<volume>181</volume>
<fpage>3755</fpage>
<lpage>3759</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.181.6.3755</pub-id>
<pub-id pub-id-type="pmid">18768827</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kool</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Soullie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>van Nimwegen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Willart</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Muskens</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoogsteden</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lambrecht</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells</article-title>
<source/>J Exp Med
          <year>2008</year>
<volume>205</volume>
<issue>4</issue>
<fpage>869</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20071087</pub-id>
<pub-id pub-id-type="pmid">18362170</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kool</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Willart</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>van Nimwegen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bergen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pouliot</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Virchow</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Osorio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Reise Sousa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lambrecht</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma</article-title>
<source/>Immunity
          <year>2011</year>
<volume>34</volume>
<issue>4</issue>
<fpage>527</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.015</pub-id>
<pub-id pub-id-type="pmid">21474346</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kool</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fierens</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lambrecht</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>Alum adjuvant: some of the tricks of the oldest adjuvant</article-title>
<source/>J Med Microbiol
          <year>2012</year>
<volume>61</volume>
<issue>Pt 7</issue>
<fpage>927</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.038943-0</pub-id>
<pub-id pub-id-type="pmid">22174375</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korczyn</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Hassin-Baer</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Can the disease course in Parkinson’s disease be slowed?</article-title>
<source/>BMC Med
          <year>2015</year>
<volume>13</volume>
<fpage>295</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-015-0534-x</pub-id>
<pub-id pub-id-type="pmid">26653056</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koufaris</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sismani</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Modulation of the genome and epigenome of individuals susceptible to autism by environmental risk factors</article-title>
<source/>Int J Mol Sci
          <year>2015</year>
<volume>16</volume>
<issue>4</issue>
<fpage>8699</fpage>
<lpage>8718</lpage>
<pub-id pub-id-type="doi">10.3390/ijms16048699</pub-id>
<pub-id pub-id-type="pmid">25903146</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: A review</article-title>
<source/>Neurotoxicology
          <year>2014</year>
<volume>41</volume>
<fpage>154</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2014.02.004</pub-id>
<pub-id pub-id-type="pmid">24560992</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium</article-title>
<source/>Brain Res
          <year>2008</year>
<volume>1232</volume>
<fpage>94</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2008.07.028</pub-id>
<pub-id pub-id-type="pmid">18691561</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dogra</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats</article-title>
<source/>Pharmacol Rep
          <year>2011</year>
<volume>63</volume>
<issue>4</issue>
<fpage>915</fpage>
<lpage>923</lpage>
<pub-id pub-id-type="doi">10.1016/S1734-1140(11)70607-7</pub-id>
<pub-id pub-id-type="pmid">22001979</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ingle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Recognition of bacterial infection by innate immune sensors</article-title>
<source/>Crit Rev Microbiol
          <year>2013</year>
<volume>39</volume>
<issue>3</issue>
<fpage>229</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.3109/1040841X.2012.706249</pub-id>
<pub-id pub-id-type="pmid">22866947</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Uematsu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ohata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Coban</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Akira</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aritake</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Urade</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms</article-title>
<source/>Immunity
          <year>2011</year>
<volume>34</volume>
<issue>4</issue>
<fpage>514</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.019</pub-id>
<pub-id pub-id-type="pmid">21497116</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ladd-Acosta</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Briem</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fallin</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Common DNA methylation alterations in multiple brain regions in autism</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<issue>8</issue>
<fpage>862</fpage>
<lpage>871</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.114</pub-id>
<pub-id pub-id-type="pmid">23999529</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Masellis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Freedman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stuss</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome</article-title>
<source/>Alzheimers Res Ther
          <year>2013</year>
<volume>5</volume>
<issue>1</issue>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/alzrt155</pub-id>
<pub-id pub-id-type="pmid">23302773</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Land</surname>
<given-names>WG</given-names>
</name>
</person-group>
<article-title>The role of damage-associated molecular patterns in human diseases: part i - promoting inflammation and immunity</article-title>
<source/>Sultan Qaboos Univ Med J
          <year>2015</year>
<volume>15</volume>
<issue>1</issue>
<fpage>e9</fpage>
<lpage>e21</lpage>
<pub-id pub-id-type="pmid">25685392</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landsberg</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Absence of aluminium in neuritic plaque cores in Alzheimer's disease</article-title>
<source/>Nature
          <year>1992</year>
<volume>360</volume>
<fpage>65</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1038/360065a0</pub-id>
<pub-id pub-id-type="pmid">1436075</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langer-Gould</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tartof</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Brara</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Beaber</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Sy</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hechter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases</article-title>
<source/>JAMA Neurol
          <year>2014</year>
<volume>71</volume>
<issue>12</issue>
<fpage>1506</fpage>
<lpage>1513</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2014.2633</pub-id>
<pub-id pub-id-type="pmid">25329096</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaSalle</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Epigenomic strategies at the interface of genetic and environmental risk factors for autism</article-title>
<source/>J Hum Genet
          <year>2013</year>
<volume>58</volume>
<issue>7</issue>
<fpage>396</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2013.49</pub-id>
<pub-id pub-id-type="pmid">23677056</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells</article-title>
<source/>Free Radic Biol Med
          <year>2002</year>
<volume>32</volume>
<issue>11</issue>
<fpage>1185</fpage>
<lpage>1196</lpage>
<pub-id pub-id-type="doi">10.1016/S0891-5849(02)00815-8</pub-id>
<pub-id pub-id-type="pmid">12031902</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemire</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>Aluminum toxicity and astrocyte dysfunction: a metabolic link to neurological disorders</article-title>
<source/>J Inorg Biochem
          <year>2011</year>
<volume>105</volume>
<issue>11</issue>
<fpage>1513</fpage>
<lpage>1517</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2011.07.001</pub-id>
<pub-id pub-id-type="pmid">22099161</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemire</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mailloux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Darwich</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Auger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>The disruption of L-carnitine metabolism by aluminum toxicity and oxidative stress promotes dyslipidemia in human astrocytic and hepatic cells</article-title>
<source/>Toxicol Lett
          <year>2011</year>
<volume>203</volume>
<issue>3</issue>
<fpage>219</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2011.03.019</pub-id>
<pub-id pub-id-type="pmid">21439360</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levandowski</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mailloux</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ferrara</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Gowan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ben</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>McFann</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Fain</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Dinarello</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Spritz</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1beta processing via the NLRP1 inflammasome</article-title>
<source/>Proc Natl Acad Sci
          <year>2013</year>
<volume>110</volume>
<issue>8</issue>
<fpage>2952</fpage>
<lpage>2956</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1222808110</pub-id>
<pub-id pub-id-type="pmid">23382179</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Willingham</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Re</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3</article-title>
<source/>J Immunol
          <year>2008</year>
<volume>181</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.181.1.17</pub-id>
<pub-id pub-id-type="pmid">18566365</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>TLR2 and TLR4 in autoimmune diseases: a comprehensive review</article-title>
<source/>Clin Rev Allergy Immunol
          <year>2014</year>
<volume>47</volume>
<issue>2</issue>
<fpage>136</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1007/s12016-013-8402-y</pub-id>
<pub-id pub-id-type="pmid">24352680</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<mixed-citation publication-type="other">Llorente-Folch I, Rueda CB, Amigo I, del Arco A, Saheki T, Pardo B, Satrustegui J (2013) Calcium-regulation of mitochondrial respiration maintains ATP homeostasis and requires ARALAR/AGC1-malate aspartate shuttle in intact cortical neurons. J Neurosci 33 (35):13957-13971, 13971a. doi:10.1523/jneurosci.0929-13.2013</mixed-citation>
</ref>
<ref id="CR148">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lovell</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Ehmann</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Markesbery</surname>
<given-names>WR</given-names>
</name>
</person-group>
<article-title>Laser microprobe analysis of brain aluminum in Alzheimer's disease</article-title>
<source/>Ann Neurol
          <year>1993</year>
<volume>33</volume>
<issue>1</issue>
<fpage>36</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410330107</pub-id>
<pub-id pub-id-type="pmid">8257483</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Optimal dose of zinc supplementation for preventing aluminum-induced neurotoxicity in rats</article-title>
<source/>Neural Regen Res
          <year>2013</year>
<volume>8</volume>
<issue>29</issue>
<fpage>2754</fpage>
<lpage>2762</lpage>
<pub-id pub-id-type="pmid">25206586</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Cognitive disorders and tau-protein expression among retired aluminum smelting workers</article-title>
<source/>J Occup Environ Med
          <year>2014</year>
<volume>56</volume>
<issue>2</issue>
<fpage>155</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1097/JOM.0000000000000100</pub-id>
<pub-id pub-id-type="pmid">24451610</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway</article-title>
<source/>Mol Neurobiol
          <year>2013</year>
<volume>48</volume>
<fpage>190</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-013-8425-7</pub-id>
<pub-id pub-id-type="pmid">23436141</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The toll-like receptor radical cycle pathway: a new drug target in immune-related chronic fatigue</article-title>
<source/>CNS Neurol Disord Drug Targets
          <year>2015</year>
<volume>14</volume>
<issue>7</issue>
<fpage>838</fpage>
<lpage>854</lpage>
<pub-id pub-id-type="doi">10.2174/1871527314666150317224645</pub-id>
<pub-id pub-id-type="pmid">25801843</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>NF-kappaB-regulated, proinflammatory miRNAs in Alzheimer's disease</article-title>
<source/>Alzheimers Res Ther
          <year>2012</year>
<volume>4</volume>
<issue>6</issue>
<fpage>47</fpage>
<pub-id pub-id-type="doi">10.1186/alzrt150</pub-id>
<pub-id pub-id-type="pmid">23217212</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lunnon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Teeling</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tutt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cragg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Glennie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration</article-title>
<source/>J Immunol
          <year>2011</year>
<volume>186</volume>
<fpage>7215</fpage>
<lpage>7224</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0903833</pub-id>
<pub-id pub-id-type="pmid">21572034</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hoa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Merryfield</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tarnawski</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement</article-title>
<source/>Microsc Res Tech
          <year>2000</year>
<volume>51</volume>
<issue>2</issue>
<fpage>156</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1002/1097-0029(20001015)51:2&lt;156::AID-JEMT7&gt;3.0.CO;2-J</pub-id>
<pub-id pub-id-type="pmid">11054866</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mailloux</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>Aluminum toxicity triggers the nuclear translocation of HIF-1alpha and promotes anaerobiosis in hepatocytes</article-title>
<source/>Toxicol in Vitro
          <year>2007</year>
<volume>21</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.tiv.2006.07.013</pub-id>
<pub-id pub-id-type="pmid">16979867</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mailloux</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>Aluminum toxicity elicits a dysfunctional TCA cycle and succinate accumulation in hepatocytes</article-title>
<source/>J Biochem Mol Toxicol
          <year>2006</year>
<volume>20</volume>
<issue>4</issue>
<fpage>198</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1002/jbt.20137</pub-id>
<pub-id pub-id-type="pmid">16906525</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mailloux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lemire</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Aluminum-induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: a link to obesity</article-title>
<source/>Cell Physiol Biochem
          <year>2007</year>
<volume>20</volume>
<issue>5</issue>
<fpage>627</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1159/000107546</pub-id>
<pub-id pub-id-type="pmid">17762189</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mailloux</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Puiseux-Dao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>Alpha-ketoglutarate abrogates the nuclear localization of HIF-1alpha in aluminum-exposed hepatocytes</article-title>
<source/>Biochimie
          <year>2009</year>
<volume>91</volume>
<issue>3</issue>
<fpage>408</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2008.10.014</pub-id>
<pub-id pub-id-type="pmid">19028544</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mailloux</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Lemire</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Appanna</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>Hepatic response to aluminum toxicity: dyslipidemia and liver diseases</article-title>
<source/>Exp Cell Res
          <year>2011</year>
<volume>317</volume>
<issue>16</issue>
<fpage>2231</fpage>
<lpage>2238</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2011.07.009</pub-id>
<pub-id pub-id-type="pmid">21787768</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannello</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ligi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Canale</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Aluminium, carbonyls and cytokines in human nipple aspirate fluids: Possible relationship between inflammation, oxidative stress and breast cancer microenvironment</article-title>
<source/>J Inorg Biochem
          <year>2013</year>
<volume>128</volume>
<fpage>250</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2013.07.003</pub-id>
<pub-id pub-id-type="pmid">23916117</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marichal</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ohata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bedoret</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mesnil</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sabatel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kobiyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lekeux</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Coban</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Akira</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Bureau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Desmet</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>DNA released from dying host cells mediates aluminum adjuvant activity</article-title>
<source/>Nat Med
          <year>2011</year>
<volume>17</volume>
<issue>8</issue>
<fpage>996</fpage>
<lpage>1002</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2403</pub-id>
<pub-id pub-id-type="pmid">21765404</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrack</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McKee</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Munks</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Towards an understanding of the adjuvant action of aluminium</article-title>
<source/>Nat Rev Immunol
          <year>2009</year>
<volume>9</volume>
<issue>4</issue>
<fpage>287</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1038/nri2510</pub-id>
<pub-id pub-id-type="pmid">19247370</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrale</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Cali</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Assessing the impact of copy number variants on miRNA genes in autism by Monte Carlo simulation</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>3</issue>
<fpage>e90947</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0090947</pub-id>
<pub-id pub-id-type="pmid">24667286</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshak-Rothstein</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Toll-like receptors in systemic autoimmune disease</article-title>
<source/>Nat Rev Immunol
          <year>2006</year>
<volume>6</volume>
<issue>11</issue>
<fpage>823</fpage>
<lpage>835</lpage>
<pub-id pub-id-type="doi">10.1038/nri1957</pub-id>
<pub-id pub-id-type="pmid">17063184</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<mixed-citation publication-type="other">Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A, Sarrazin S, Ben-Yehuda H, David E, Zelada González F, Perrin P, Keren-Shaul H, Gury M, Lara-Astaiso D, Thaiss CA, Cohen M, Bahar Halpern K, Baruch K, Deczkowska A, Lorenzo-Vivas E, Itzkovitz S, Elinav E, Sieweke MH, Schwartz M, Amit I (2016) Microglia development follows a stepwise program to regulate brain homeostasis. Science 353(6301):aad8670. doi: 10.1126/science.aad8670</mixed-citation>
</ref>
<ref id="CR167">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDougle</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Landino</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Vahabzadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O'Rourke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zurcher</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Finger</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Palumbo</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Helt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mullett</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Hooker</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Carlezon</surname>
<given-names>WA</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Toward an immune-mediated subtype of autism spectrum disorder</article-title>
<source/>Brain Res
          <year>2015</year>
<volume>1617</volume>
<fpage>72</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2014.09.048</pub-id>
<pub-id pub-id-type="pmid">25445995</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mead</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Evidence supporting an altered immune response in ASD</article-title>
<source/>Immunol Lett
          <year>2015</year>
<volume>163</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.imlet.2014.11.006</pub-id>
<pub-id pub-id-type="pmid">25448709</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellios</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sur</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders</article-title>
<source/>Front Psychiatry
          <year>2012</year>
<volume>3</volume>
<fpage>39</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2012.00039</pub-id>
<pub-id pub-id-type="pmid">22539927</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melnyk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kahler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fussell</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism</article-title>
<source/>J Autism Dev Disord
          <year>2012</year>
<volume>42</volume>
<fpage>367</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-011-1260-7</pub-id>
<pub-id pub-id-type="pmid">21519954</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Mirnics</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Immune system gene dysregulation in autism and schizophrenia</article-title>
<source/>Developl Neurobiol
          <year>2012</year>
<volume>72</volume>
<issue>10</issue>
<fpage>1277</fpage>
<lpage>1287</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22044</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miranda-Hernandez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Role of toll-like receptors in multiple sclerosis</article-title>
<source/>Am J Clin Exp Immunol
          <year>2013</year>
<volume>2</volume>
<fpage>75</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">23885326</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed Fel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zaky</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>El-Sayed</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Elhossieny</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Zahra</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Salah Eldin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Youssef</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Khaled</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Youssef</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Assessment of Hair Aluminum, Lead, and Mercury in a Sample of Autistic Egyptian Children: Environmental Risk Factors of Heavy Metals in Autism</article-title>
<source/>Behav Neurol
          <year>2015</year>
<volume>2015</volume>
<fpage>545674</fpage>
<pub-id pub-id-type="pmid">26508811</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Alleyne</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Adogwa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The effects of ingested aluminium on brain cytochrome oxidase activity</article-title>
<source/>West Indian Med J
          <year>2009</year>
<volume>58</volume>
<issue>5</issue>
<fpage>422</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">20441059</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molofsky</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Krenick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ullian</surname>
<given-names>E</given-names>
</name>
<name>
<surname>H-h</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Deneen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Rowitch</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Astrocytes and disease: a neurodevelopmental perspective</article-title>
<source/>Genes Dev
          <year>2012</year>
<volume>26</volume>
<issue>9</issue>
<fpage>891</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="doi">10.1101/gad.188326.112</pub-id>
<pub-id pub-id-type="pmid">22549954</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nardone</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sams</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex</article-title>
<source/>Molecular Autism
          <year>2015</year>
<volume>6</volume>
<fpage>46</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0040-1</pub-id>
<pub-id pub-id-type="pmid">26273428</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moraes</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Benedet</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Souza</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Lins</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Camargos</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Naves</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Cordova</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Nobrega</surname>
<given-names>OT</given-names>
</name>
</person-group>
<article-title>Cytokine gene polymorphisms and Alzheimer's disease in Brazil</article-title>
<source/>Neuroimmunomodulation
          <year>2013</year>
<volume>20</volume>
<issue>5</issue>
<fpage>239</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1159/000350368</pub-id>
<pub-id pub-id-type="pmid">23838435</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chana</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Achim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Semendeferi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Buckwalter</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism</article-title>
<source/>Biol Psychiatry
          <year>2010</year>
<volume>68</volume>
<fpage>368</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.024</pub-id>
<pub-id pub-id-type="pmid">20674603</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Chana</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Semendeferi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Everall</surname>
<given-names>IP</given-names>
</name>
</person-group>
<article-title>Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism</article-title>
<source/>Brain Res
          <year>2012</year>
<volume>1456</volume>
<fpage>72</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2012.03.036</pub-id>
<pub-id pub-id-type="pmid">22516109</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders</article-title>
<source/>BMC Med
          <year>2015</year>
<volume>13</volume>
<issue>1</issue>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-015-0310-y</pub-id>
<pub-id pub-id-type="pmid">25889215</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The Putative Use of Lithium in Alzheimer's Disease</article-title>
<source/>Curr Alzheimer Res
          <year>2016</year>
<volume>13</volume>
<issue>8</issue>
<fpage>853</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="doi">10.2174/1567205013666160219113112</pub-id>
<pub-id pub-id-type="pmid">26892287</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<mixed-citation publication-type="other">Morris G, Maes M (2012) A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome. Metab Brain Dis 28:523–540. doi:10.1007/s11011-012-9324-8</mixed-citation>
</ref>
<ref id="CR183">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Oxidative and nitrosative stress and immune-inflammatory pathways in patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)</article-title>
<source/>Curr Neuropharmacol
          <year>2014</year>
<volume>12</volume>
<fpage>168</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.2174/1570159X11666131120224653</pub-id>
<pub-id pub-id-type="pmid">24669210</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Galecki</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Walder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases</article-title>
<source/>Mol Neurobiol
          <year>2015</year>
<volume>53</volume>
<issue>2</issue>
<fpage>1195</fpage>
<lpage>1219</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-015-9090-9</pub-id>
<pub-id pub-id-type="pmid">25598355</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Walder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses</article-title>
<source/>BMC Med
          <year>2015</year>
<volume>13</volume>
<issue>1</issue>
<fpage>28</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-014-0259-2</pub-id>
<pub-id pub-id-type="pmid">25856766</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mostafa</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Shehab</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Al-Ayadhi</surname>
<given-names>LY</given-names>
</name>
</person-group>
<article-title>The link between some alleles on human leukocyte antigen system and autism in children</article-title>
<source/>J Neuroimmunol
          <year>2013</year>
<volume>255</volume>
<issue>1–2</issue>
<fpage>70</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2012.10.002</pub-id>
<pub-id pub-id-type="pmid">23110937</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mundalil Vasu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anitha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thanseem</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wakuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsujii</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Serum microRNA profiles in children with autism</article-title>
<source/>Molecular Autism
          <year>2014</year>
<volume>5</volume>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-40</pub-id>
<pub-id pub-id-type="pmid">25126405</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munks</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>McKee</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Macleod</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Degen</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Reisdorph</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Kappler</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Marrack</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo</article-title>
<source/>Blood
          <year>2010</year>
<volume>116</volume>
<issue>24</issue>
<fpage>5191</fpage>
<lpage>5199</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2010-03-275529</pub-id>
<pub-id pub-id-type="pmid">20876456</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murakami</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshino</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Aluminum decreases the glutathione regeneration by the inhibition of NADP-isocitrate dehydrogenase in mitochondria</article-title>
<source/>J Cell Biochem
          <year>2004</year>
<volume>93</volume>
<issue>6</issue>
<fpage>1267</fpage>
<lpage>1271</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.20261</pub-id>
<pub-id pub-id-type="pmid">15486972</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mustafa Rizvi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Parveen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Arshad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mahdi</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Aluminium induced endoplasmic reticulum stress mediated cell death in SH-SY5Y neuroblastoma cell line is independent of p53</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>5</issue>
<fpage>e98409</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0098409</pub-id>
<pub-id pub-id-type="pmid">24878590</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagai</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Perinatal innate immune activation and neuropsychological development</article-title>
<source/>Nihon Shinkei Seishin Yakurigaku Zasshi
          <year>2013</year>
<volume>33</volume>
<issue>4</issue>
<fpage>149</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="pmid">25069250</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nampoothiri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>John</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mudgal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nampurath</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Chamallamudi</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Modulatory role of simvastatin against aluminium chloride-induced behavioural and biochemical changes in rats</article-title>
<source/>Behav Neurol
          <year>2015</year>
<volume>2015</volume>
<fpage>210169</fpage>
<pub-id pub-id-type="doi">10.1155/2015/210169</pub-id>
<pub-id pub-id-type="pmid">25802481</pub-id>
</element-citation>
</ref>
<ref id="CR193">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napoli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giulivi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism</article-title>
<source/>Molecular Autism
          <year>2013</year>
<volume>4</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-2</pub-id>
<pub-id pub-id-type="pmid">23311570</pub-id>
</element-citation>
</ref>
<ref id="CR194">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nardone</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharan Sams</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Reuveni</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Getselter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Oron</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Karpuj</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways</article-title>
<source/>Transl Psychiatry
          <year>2014</year>
<volume>4</volume>
<fpage>e433</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.70</pub-id>
<pub-id pub-id-type="pmid">25180572</pub-id>
</element-citation>
</ref>
<ref id="CR195">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Netea</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Wijmenga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>O'Neill</surname>
<given-names>LAJ</given-names>
</name>
</person-group>
<article-title>Genetic variation in Toll-like receptors and disease susceptibility</article-title>
<source/>Nat Immunol
          <year>2012</year>
<volume>13</volume>
<issue>6</issue>
<fpage>535</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1038/ni.2284</pub-id>
<pub-id pub-id-type="pmid">22610250</pub-id>
</element-citation>
</ref>
<ref id="CR196">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis</article-title>
<source/>J Neuroimmunol
          <year>2007</year>
<volume>184</volume>
<issue>1–2</issue>
<fpage>92</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2006.11.032</pub-id>
<pub-id pub-id-type="pmid">17239445</pub-id>
</element-citation>
</ref>
<ref id="CR197">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newairy</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Salama</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Hussien</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Yousef</surname>
<given-names>MI</given-names>
</name>
</person-group>
<article-title>Propolis alleviates aluminium-induced lipid peroxidation and biochemical parameters in male rats</article-title>
<source/>Food Chem Toxicol
          <year>2009</year>
<volume>47</volume>
<issue>6</issue>
<fpage>1093</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2009.01.032</pub-id>
<pub-id pub-id-type="pmid">19425229</pub-id>
</element-citation>
</ref>
<ref id="CR198">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noriega</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Savelkoul</surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>Immune dysregulation in autism spectrum disorder</article-title>
<source/>Eur J Pediatr
          <year>2014</year>
<volume>173</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-013-2183-4</pub-id>
<pub-id pub-id-type="pmid">24297668</pub-id>
</element-citation>
</ref>
<ref id="CR199">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orihuela</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Meichtry</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pizarro</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Aluminium-induced impairment of transcellular calcium absorption in the small intestine: calcium uptake and glutathione influence</article-title>
<source/>J Inorg Biochem
          <year>2005</year>
<volume>99</volume>
<issue>9</issue>
<fpage>1879</fpage>
<lpage>1886</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2005.07.003</pub-id>
<pub-id pub-id-type="pmid">16055194</pub-id>
</element-citation>
</ref>
<ref id="CR200">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pacheco-Moises</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bitzer-Quintero</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ramirez-Anguiano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Flores-Alvarado</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ramirez-Ramirez</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Immunology and oxidative stress in multiple sclerosis: clinical and basic approach</article-title>
<source/>Clin Dev Immunol
          <year>2013</year>
<volume>2013</volume>
<fpage>708659</fpage>
<pub-id pub-id-type="doi">10.1155/2013/708659</pub-id>
<pub-id pub-id-type="pmid">24174971</pub-id>
</element-citation>
</ref>
<ref id="CR201">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ottoboni</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Frohlich</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Keenan</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chitnis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Guttmann</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Hafler</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>De Jager</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus</article-title>
<source/>Neurology
          <year>2013</year>
<volume>81</volume>
<issue>22</issue>
<fpage>1891</fpage>
<lpage>1899</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000436612.66328.8a</pub-id>
<pub-id pub-id-type="pmid">24174586</pub-id>
</element-citation>
</ref>
<ref id="CR202">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Painter</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Atagi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fryer</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>TREM2 in CNS homeostasis and neurodegenerative disease</article-title>
<source/>Mol Neurodegener
          <year>2015</year>
<volume>10</volume>
<fpage>43</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-015-0040-9</pub-id>
<pub-id pub-id-type="pmid">26337043</pub-id>
</element-citation>
</ref>
<ref id="CR203">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paradowska-Gorycka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jurkowska</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12</article-title>
<source/>Hum Immunol
          <year>2013</year>
<volume>74</volume>
<issue>6</issue>
<fpage>730</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="doi">10.1016/j.humimm.2013.02.003</pub-id>
<pub-id pub-id-type="pmid">23459077</pub-id>
</element-citation>
</ref>
<ref id="CR204">
<mixed-citation publication-type="other">Paz Soldan MM, Rodriguez M (2002) Heterogeneity of Pathogenesis in Multiple Sclerosis: Implications for Promotion of Remyelination. Journal of Infectious Diseases 186 (Supplement 2):S248-S253. doi:10.1086/344283</mixed-citation>
</ref>
<ref id="CR205">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellegrino</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Clementi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Radice</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives</article-title>
<source/>Autoimmun Rev
          <year>2015</year>
<volume>14</volume>
<issue>10</issue>
<fpage>880</fpage>
<lpage>888</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2015.05.014</pub-id>
<pub-id pub-id-type="pmid">26031899</pub-id>
</element-citation>
</ref>
<ref id="CR206">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelly</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vardy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Newhook</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Chafe</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Incidence and cohort prevalence for autism spectrum disorders in the Avalon Peninsula, Newfoundland and Labrador</article-title>
<source/>CMAJ Open
          <year>2015</year>
<volume>3</volume>
<issue>3</issue>
<fpage>E276</fpage>
<lpage>E280</lpage>
<pub-id pub-id-type="doi">10.9778/cmajo.20140056</pub-id>
<pub-id pub-id-type="pmid">26442225</pub-id>
</element-citation>
</ref>
<ref id="CR207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Humphrey</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages</article-title>
<source/>Sci Signal
          <year>2013</year>
<volume>6</volume>
<issue>289</issue>
<fpage>ra72</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.2003801</pub-id>
<pub-id pub-id-type="pmid">23962980</pub-id>
</element-citation>
</ref>
<ref id="CR208">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perricone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Colafrancesco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mazor</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Soriano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects</article-title>
<source/>J Autoimmun
          <year>2013</year>
<volume>47</volume>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2013.10.004</pub-id>
<pub-id pub-id-type="pmid">24238833</pub-id>
</element-citation>
</ref>
<ref id="CR209">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Microglial priming in neurodegenerative disease</article-title>
<source/>Nat Rev Neurol
          <year>2014</year>
<volume>10</volume>
<fpage>217</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2014.38</pub-id>
<pub-id pub-id-type="pmid">24638131</pub-id>
</element-citation>
</ref>
<ref id="CR210">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Microglia in neurodegenerative disease</article-title>
<source/>Nat Rev Neurol
          <year>2010</year>
<volume>6</volume>
<fpage>193</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2010.17</pub-id>
<pub-id pub-id-type="pmid">20234358</pub-id>
</element-citation>
</ref>
<ref id="CR211">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrovsky</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs</article-title>
<source/>Drug Saf
          <year>2015</year>
<volume>38</volume>
<issue>11</issue>
<fpage>1059</fpage>
<lpage>1074</lpage>
<pub-id pub-id-type="doi">10.1007/s40264-015-0350-4</pub-id>
<pub-id pub-id-type="pmid">26446142</pub-id>
</element-citation>
</ref>
<ref id="CR212">
<mixed-citation publication-type="other">Piccinini AM, Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediat Inflamm 2010. doi:10.1155/2010/672395</mixed-citation>
</ref>
<ref id="CR213">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pineton de Chambrun</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Body-Malapel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frey-Wagner</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Djouina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deknuydt</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Atrott</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Esquerre</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Altare</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Neut</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Arrieta</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kanneganti</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Rogler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Colombel</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Cortot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Desreumaux</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vignal</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice</article-title>
<source/>Mucosal Immunol
          <year>2014</year>
<volume>7</volume>
<issue>3</issue>
<fpage>589</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1038/mi.2013.78</pub-id>
<pub-id pub-id-type="pmid">24129165</pub-id>
</element-citation>
</ref>
<ref id="CR214">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pogue</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kruck</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Tarr</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells</article-title>
<source/>J Inorg Biochem
          <year>2009</year>
<volume>103</volume>
<issue>11</issue>
<fpage>1591</fpage>
<lpage>1595</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2009.05.012</pub-id>
<pub-id pub-id-type="pmid">19540598</pub-id>
</element-citation>
</ref>
<ref id="CR215">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poland</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>McKinney</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Oberg</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century</article-title>
<source/>Semin Immunol
          <year>2013</year>
<volume>25</volume>
<issue>2</issue>
<fpage>89</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.smim.2013.04.007</pub-id>
<pub-id pub-id-type="pmid">23755893</pub-id>
</element-citation>
</ref>
<ref id="CR216">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poliani</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fontana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Robinette</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Yamanishi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gilfillan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Colonna</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>TREM2 sustains microglial expansion during aging and response to demyelination</article-title>
<source/>J Clin Invest
          <year>2015</year>
<volume>125</volume>
<issue>5</issue>
<fpage>2161</fpage>
<lpage>2170</lpage>
<pub-id pub-id-type="doi">10.1172/JCI77983</pub-id>
<pub-id pub-id-type="pmid">25893602</pub-id>
</element-citation>
</ref>
<ref id="CR217">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pontillo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Girardelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Pancotto</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Donadi</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Crovella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sandrin-Garcia</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus</article-title>
<source/>Autoimmunity
          <year>2012</year>
<volume>45</volume>
<issue>4</issue>
<fpage>271</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.3109/08916934.2011.637532</pub-id>
<pub-id pub-id-type="pmid">22235789</pub-id>
</element-citation>
</ref>
<ref id="CR218">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Andrianov</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Fusco</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes</article-title>
<source/>Clin Exper Vacc Res
          <year>2015</year>
<volume>4</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.7774/cevr.2015.4.1.23</pub-id>
</element-citation>
</ref>
<ref id="CR219">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pradhan</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Surve</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Toll-like receptors in autoimmunity with special reference to systemic lupus erythematosus</article-title>
<source/>Indian J Human Gene
          <year>2012</year>
<volume>18</volume>
<issue>2</issue>
<fpage>155</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.4103/0971-6866.100750</pub-id>
</element-citation>
</ref>
<ref id="CR220">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramparo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Carter Barnes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marinero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahrens-Barbeau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Prediction of autism by translation and immune/inflammation coexpressed genes in toddlers from pediatric community practices</article-title>
<source/>JAMA Psychiatry
          <year>2015</year>
<volume>72</volume>
<issue>4</issue>
<fpage>386</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.3008</pub-id>
<pub-id pub-id-type="pmid">25739104</pub-id>
</element-citation>
</ref>
<ref id="CR221">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rainbolt</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Wiseman</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Stress-responsive regulation of mitochondria through the ER unfolded protein response</article-title>
<source/>Trends Endocrinol Metab
          <year>2014</year>
<volume>25</volume>
<issue>10</issue>
<fpage>528</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1016/j.tem.2014.06.007</pub-id>
<pub-id pub-id-type="pmid">25048297</pub-id>
</element-citation>
</ref>
<ref id="CR222">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Sajuthi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Langefeld</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder</article-title>
<source/>Molecular Autism
          <year>2012</year>
<volume>3</volume>
<fpage>4</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-4</pub-id>
<pub-id pub-id-type="pmid">22681640</pub-id>
</element-citation>
</ref>
<ref id="CR223">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangasamy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>D'Mello</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Epigenetics, autism spectrum, and neurodevelopmental disorders</article-title>
<source/>Neurotherapeutics
          <year>2013</year>
<volume>10</volume>
<issue>4</issue>
<fpage>742</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-013-0227-0</pub-id>
<pub-id pub-id-type="pmid">24104594</pub-id>
</element-citation>
</ref>
<ref id="CR224">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Giedd</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Gogtay</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental model of schizophrenia: update 2012</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<issue>12</issue>
<fpage>1228</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.23</pub-id>
<pub-id pub-id-type="pmid">22488257</pub-id>
</element-citation>
</ref>
<ref id="CR225">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reuter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chaturvedi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Oxidative stress, inflammation, and cancer: how are they linked?</article-title>
<source/>Free Radic Biol Med
          <year>2010</year>
<volume>49</volume>
<fpage>1603</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.09.006</pub-id>
<pub-id pub-id-type="pmid">20840865</pub-id>
</element-citation>
</ref>
<ref id="CR226">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Lyall</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Laden</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Just</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Bobb</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Koenen</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Ascherio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weisskopf</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants</article-title>
<source/>Environ Health Perspect
          <year>2013</year>
<volume>121</volume>
<issue>8</issue>
<fpage>978</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="pmid">23816781</pub-id>
</element-citation>
</ref>
<ref id="CR227">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rondeau</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Jacqmin-Gadda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Commenges</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Helmer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dartigues</surname>
<given-names>J-F</given-names>
</name>
</person-group>
<article-title>Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort</article-title>
<source/>Am J Epidemiol
          <year>2009</year>
<volume>169</volume>
<issue>4</issue>
<fpage>489</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1093/aje/kwn348</pub-id>
<pub-id pub-id-type="pmid">19064650</pub-id>
</element-citation>
</ref>
<ref id="CR228">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossignol</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism</article-title>
<source/>Front Physiol
          <year>2014</year>
<volume>5</volume>
<fpage>150</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2014.00150</pub-id>
<pub-id pub-id-type="pmid">24795645</pub-id>
</element-citation>
</ref>
<ref id="CR229">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rueda</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Llorente-Folch</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Amigo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gonzalez-Sanchez</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Martinez-Valero</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Juaristi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>del Arco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Satrustegui</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Ca(2+) regulation of mitochondrial function in neurons</article-title>
<source/>Biochim Biophys Acta
          <year>2014</year>
<volume>1837</volume>
<issue>10</issue>
<fpage>1617</fpage>
<lpage>1624</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbabio.2014.04.010</pub-id>
<pub-id pub-id-type="pmid">24820519</pub-id>
</element-citation>
</ref>
<ref id="CR230">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruggeri</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sarkans</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Biomarkers in autism spectrum disorder: the old and the new</article-title>
<source/>Psychopharmacology
          <year>2014</year>
<volume>231</volume>
<issue>6</issue>
<fpage>1201</fpage>
<lpage>1216</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-013-3290-7</pub-id>
<pub-id pub-id-type="pmid">24096533</pub-id>
</element-citation>
</ref>
<ref id="CR231">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Incidence of autism spectrum disorders: changes over time and their meaning</article-title>
<source/>Acta Paediatr
          <year>2005</year>
<volume>94</volume>
<issue>1</issue>
<fpage>2</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1080/08035250410023124</pub-id>
<pub-id pub-id-type="pmid">15858952</pub-id>
</element-citation>
</ref>
<ref id="CR232">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Theisen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Ravnan</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Neill</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Casci</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bejjani</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems</article-title>
<source/>Gene Med
          <year>2011</year>
<volume>13</volume>
<issue>10</issue>
<fpage>868</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3182217a06</pub-id>
</element-citation>
</ref>
<ref id="CR233">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saresella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Piancone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marventano</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Zoppis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hernis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zanette</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trabattoni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chiappedi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghezzo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Canevini</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>la Rosa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Clerici</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Multiple inflammasome complexes are activated in autistic spectrum disorders</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>57</volume>
<fpage>125</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2016.03.009</pub-id>
<pub-id pub-id-type="pmid">26979869</pub-id>
</element-citation>
</ref>
<ref id="CR234">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheller</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Svanstrom</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pasternak</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Arnheim-Dahlstrom</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sundstrom</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hviid</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system</article-title>
<source/>JAMA
          <year>2015</year>
<volume>313</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.16946</pub-id>
<pub-id pub-id-type="pmid">25562266</pub-id>
</element-citation>
</ref>
<ref id="CR235">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schepens</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Schonewille</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Vink</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van Schothorst</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hendriks</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brummer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Keijer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bovee-Oudenhoven</surname>
<given-names>IM</given-names>
</name>
</person-group>
<article-title>Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats</article-title>
<source/>J Nutr
          <year>2009</year>
<volume>139</volume>
<issue>8</issue>
<fpage>1525</fpage>
<lpage>1533</lpage>
<pub-id pub-id-type="doi">10.3945/jn.109.105205</pub-id>
<pub-id pub-id-type="pmid">19535420</pub-id>
</element-citation>
</ref>
<ref id="CR236">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Sunkaria</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wani</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Kandimalla</surname>
<given-names>RJL</given-names>
</name>
<name>
<surname>Bal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Aluminium induced oxidative stress results in decreased mitochondrial biogenesis via modulation of PGC-1α expression</article-title>
<source/>Toxicol Appl Pharmacol
          <year>2013</year>
<volume>273</volume>
<issue>2</issue>
<fpage>365</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2013.09.012</pub-id>
<pub-id pub-id-type="pmid">24084166</pub-id>
</element-citation>
</ref>
<ref id="CR237">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharp</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Ruane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Claass</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Creagh</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Malyala</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>O'Hagan</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Petrilli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tschopp</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O'Neill</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Lavelle</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2009</year>
<volume>106</volume>
<issue>3</issue>
<fpage>870</fpage>
<lpage>875</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0804897106</pub-id>
<pub-id pub-id-type="pmid">19139407</pub-id>
</element-citation>
</ref>
<ref id="CR238">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shastri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonifati</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Kishore</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Innate Immunity and Neuroinflammation</article-title>
<source/>Mediat Inflamm
          <year>2013</year>
<volume>2013</volume>
<fpage>342931</fpage>
<pub-id pub-id-type="doi">10.1155/2013/342931</pub-id>
</element-citation>
</ref>
<ref id="CR239">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Tomljenovic</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity</article-title>
<source/>Immunol Res
          <year>2013</year>
<volume>56</volume>
<issue>2–3</issue>
<fpage>304</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1007/s12026-013-8403-1</pub-id>
<pub-id pub-id-type="pmid">23609067</pub-id>
</element-citation>
</ref>
<ref id="CR240">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Rock</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>Molecular identification of a danger signal that alerts the immune system to dying cells</article-title>
<source/>Nature
          <year>2003</year>
<volume>425</volume>
<issue>6957</issue>
<fpage>516</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1038/nature01991</pub-id>
<pub-id pub-id-type="pmid">14520412</pub-id>
</element-citation>
</ref>
<ref id="CR241">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants</article-title>
<source/>J Autoimmun
          <year>2011</year>
<volume>36</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2010.07.003</pub-id>
<pub-id pub-id-type="pmid">20708902</pub-id>
</element-citation>
</ref>
<ref id="CR242">
<mixed-citation publication-type="other">Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT (2014) Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci 8(315). doi:10.3389/fnins.2014.00315</mixed-citation>
</ref>
<ref id="CR243">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siniscalco</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder</article-title>
<source/>Front Psychiatry
          <year>2015</year>
<volume>6</volume>
<fpage>145</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2015.00145</pub-id>
<pub-id pub-id-type="pmid">26500565</pub-id>
</element-citation>
</ref>
<ref id="CR244">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siniscalco</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cirillo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bradstreet</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Antonucci</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Epigenetic Findings in Autism: New Perspectives for Therapy</article-title>
<source/>Int J Environ Res Public Health
          <year>2013</year>
<volume>10</volume>
<issue>9</issue>
<fpage>4261</fpage>
<lpage>4273</lpage>
<pub-id pub-id-type="doi">10.3390/ijerph10094261</pub-id>
<pub-id pub-id-type="pmid">24030655</pub-id>
</element-citation>
</ref>
<ref id="CR245">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sloan</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Glia as primary drivers of neuropathology in TDP-43 proteinopathies</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<issue>12</issue>
<fpage>4439</fpage>
<lpage>4440</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1301608110</pub-id>
<pub-id pub-id-type="pmid">23471990</pub-id>
</element-citation>
</ref>
<ref id="CR246">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smeeth</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Heavey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>MMR vaccination and pervasive developmental disorders: a case-control study</article-title>
<source/>Lancet
          <year>2004</year>
<volume>364</volume>
<issue>9438</issue>
<fpage>963</fpage>
<lpage>969</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(04)17020-7</pub-id>
<pub-id pub-id-type="pmid">15364187</pub-id>
</element-citation>
</ref>
<ref id="CR247">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soriano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nesher</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Predicting post-vaccination autoimmunity: who might be at risk?</article-title>
<source/>Pharmacol Res
          <year>2015</year>
<volume>92</volume>
<fpage>18</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2014.08.002</pub-id>
<pub-id pub-id-type="pmid">25277820</pub-id>
</element-citation>
</ref>
<ref id="CR248">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stetson</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Medzhitov</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Recognition of cytosolic DNA activates an IRF3-dependent innate immune response</article-title>
<source/>Immunity
          <year>2006</year>
<volume>24</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2005.12.003</pub-id>
<pub-id pub-id-type="pmid">16413926</pub-id>
</element-citation>
</ref>
<ref id="CR249">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Struys-Ponsar</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guillard</surname>
<given-names>O</given-names>
</name>
<name>
<surname>van den Bosch de Aguilar</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Effects of aluminum exposure on glutamate metabolism: a possible explanation for its toxicity</article-title>
<source/>Exp Neurol
          <year>2000</year>
<volume>163</volume>
<issue>1</issue>
<fpage>157</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1006/exnr.2000.7355</pub-id>
<pub-id pub-id-type="pmid">10785454</pub-id>
</element-citation>
</ref>
<ref id="CR250">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Federoff</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Immune responses in Parkinson's disease: interplay between central and peripheral immune systems</article-title>
<source/>Biomed Res Int
          <year>2014</year>
<volume>2014</volume>
<fpage>275178</fpage>
<pub-id pub-id-type="pmid">24822191</pub-id>
</element-citation>
</ref>
<ref id="CR251">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suarez-Fernandez</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Soldado</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Sanz-Medel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vega</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fernandez-Sanchez</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death</article-title>
<source/>Brain Res
          <year>1999</year>
<volume>835</volume>
<issue>2</issue>
<fpage>125</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(99)01536-X</pub-id>
<pub-id pub-id-type="pmid">10415367</pub-id>
</element-citation>
</ref>
<ref id="CR252">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sumathi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shobana</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thangarajeswari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Usha</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Protective effect of L-Theanine against aluminium induced neurotoxicity in cerebral cortex, hippocampus and cerebellum of rat brain - histopathological, and biochemical approach</article-title>
<source/>Drug Chem Toxicol
          <year>2015</year>
<volume>38</volume>
<issue>1</issue>
<fpage>22</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.3109/01480545.2014.900068</pub-id>
<pub-id pub-id-type="pmid">24654859</pub-id>
</element-citation>
</ref>
<ref id="CR253">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sugihara</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ouchi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Futatsubashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takebayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Omata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsujii</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Microglial activation in young adults with autism spectrum disorder</article-title>
<source/>JAMA Psychiatry
          <year>2013</year>
<volume>70</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.272</pub-id>
<pub-id pub-id-type="pmid">23404112</pub-id>
</element-citation>
</ref>
<ref id="CR254">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rochford</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2</article-title>
<source/>J Exp Med
          <year>2005</year>
<volume>201</volume>
<issue>4</issue>
<fpage>647</fpage>
<lpage>657</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20041611</pub-id>
<pub-id pub-id-type="pmid">15728241</pub-id>
</element-citation>
</ref>
<ref id="CR255">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Prinz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stagi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chechneva</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis</article-title>
<source/>PLoS Med
          <year>2007</year>
<volume>4</volume>
<issue>4</issue>
<fpage>e124</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.0040124</pub-id>
<pub-id pub-id-type="pmid">17425404</pub-id>
</element-citation>
</ref>
<ref id="CR256">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tammimies</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Woodbury-Smith</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gazzellone</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Whitten</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vardy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Crosbie</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>D'Abate</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Luscombe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Stuckless</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stavropoulos</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder</article-title>
<source/>JAMA
          <year>2015</year>
<volume>314</volume>
<issue>9</issue>
<fpage>895</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2015.10078</pub-id>
<pub-id pub-id-type="pmid">26325558</pub-id>
</element-citation>
</ref>
<ref id="CR257">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese</article-title>
<source/>J Neuroimmunol
          <year>2013</year>
<volume>265</volume>
<issue>1–2</issue>
<fpage>91</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2013.10.002</pub-id>
<pub-id pub-id-type="pmid">24144834</pub-id>
</element-citation>
</ref>
<ref id="CR258">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Swerdfeger</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Eslick</surname>
<given-names>GD</given-names>
</name>
</person-group>
<article-title>Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies</article-title>
<source/>Vaccine
          <year>2014</year>
<volume>32</volume>
<issue>29</issue>
<fpage>3623</fpage>
<lpage>3629</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.04.085</pub-id>
<pub-id pub-id-type="pmid">24814559</pub-id>
</element-citation>
</ref>
<ref id="CR259">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Kaminski</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kurt-Jones</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Pattern Recognition Receptors and the Innate Immune Response to Viral Infection</article-title>
<source/>Viruses
          <year>2011</year>
<volume>3</volume>
<issue>6</issue>
<fpage>920</fpage>
<lpage>940</lpage>
<pub-id pub-id-type="doi">10.3390/v3060920</pub-id>
<pub-id pub-id-type="pmid">21994762</pub-id>
</element-citation>
</ref>
<ref id="CR260">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thrash</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Torbett</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease</article-title>
<source/>Neurochem Res
          <year>2009</year>
<volume>34</volume>
<issue>1</issue>
<fpage>38</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-008-9657-1</pub-id>
<pub-id pub-id-type="pmid">18404378</pub-id>
</element-citation>
</ref>
<ref id="CR261">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tordjman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Somogyi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Coulon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kermarrec</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bronsard</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bonnot</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Weismann-Arcache</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Botbol</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lauth</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ginchat</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Roubertoux</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barburoth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kovess</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Geoffray</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Gene x Environment interactions in autism spectrum disorders: role of epigenetic mechanisms</article-title>
<source/>Front Psychiatry
          <year>2014</year>
<volume>5</volume>
<fpage>53</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2014.00053</pub-id>
<pub-id pub-id-type="pmid">25136320</pub-id>
</element-citation>
</ref>
<ref id="CR262">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Westover</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Rosenspire</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>HLA Immune Function Genes in Autism</article-title>
<source/>Autism Res Treat
          <year>2012</year>
<volume>2012</volume>
<fpage>959073</fpage>
<pub-id pub-id-type="pmid">22928105</pub-id>
</element-citation>
</ref>
<ref id="CR263">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tunçbilek</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection</article-title>
<source/>World J Gastroenterol
          <year>2014</year>
<volume>20</volume>
<issue>20</issue>
<fpage>6226</fpage>
<lpage>6235</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i20.6226</pub-id>
<pub-id pub-id-type="pmid">24876743</pub-id>
</element-citation>
</ref>
<ref id="CR264">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaishnavi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Manikandan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tiwary</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Munirajan</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Insights on the functional impact of microRNAs present in autism-associated copy number variants</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>2</issue>
<fpage>e56781</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056781</pub-id>
<pub-id pub-id-type="pmid">23451085</pub-id>
</element-citation>
</ref>
<ref id="CR265">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vannuvel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Renard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arnould</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Functional and morphological impact of ER stress on mitochondria</article-title>
<source/>J Cell Physiol
          <year>2013</year>
<volume>228</volume>
<issue>9</issue>
<fpage>1802</fpage>
<lpage>1818</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.24360</pub-id>
<pub-id pub-id-type="pmid">23629871</pub-id>
</element-citation>
</ref>
<ref id="CR266">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venegas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heneka</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Danger-associated molecular patterns in Alzheimer’s disease</article-title>
<source/>J Leukoc Biol
          <year>2017</year>
<volume>101</volume>
<issue>1</issue>
<fpage>87</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.3MR0416-204R</pub-id>
<pub-id pub-id-type="pmid">28049142</pub-id>
</element-citation>
</ref>
<ref id="CR267">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vera-Lastra</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cruz-Dominguez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jara</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum</article-title>
<source/>Expert Rev Clin Immunol
          <year>2013</year>
<volume>9</volume>
<fpage>361</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1586/eci.13.2</pub-id>
<pub-id pub-id-type="pmid">23557271</pub-id>
</element-citation>
</ref>
<ref id="CR268">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verstraeten</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>DeStefano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lieu</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Rhodes</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Shinefield</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases</article-title>
<source/>Pediatrics
          <year>2003</year>
<volume>112</volume>
<issue>5</issue>
<fpage>1039</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="pmid">14595043</pub-id>
</element-citation>
</ref>
<ref id="CR269">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Gene expression studies in autism: moving from the genome to the transcriptome and beyond</article-title>
<source/>Neurobiol Dis
          <year>2012</year>
<volume>45</volume>
<issue>1</issue>
<fpage>69</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.07.017</pub-id>
<pub-id pub-id-type="pmid">21839838</pub-id>
</element-citation>
</ref>
<ref id="CR270">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Eapen</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Converging Pathways in Autism Spectrum Disorders: Interplay Between Synaptic Dysfunction and Immune Responses</article-title>
<source/>Front Hum Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>738</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2013.00738</pub-id>
<pub-id pub-id-type="pmid">24223544</pub-id>
</element-citation>
</ref>
<ref id="CR271">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id>
</element-citation>
</ref>
<ref id="CR272">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Aluminum in hippocampal neurons from humans with Alzheimer's disease</article-title>
<source/>Neurotoxicology
          <year>2006</year>
<volume>27</volume>
<issue>3</issue>
<fpage>385</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2005.11.007</pub-id>
<pub-id pub-id-type="pmid">16458972</pub-id>
</element-citation>
</ref>
<ref id="CR273">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease</article-title>
<source/>J Alzheimers Dis
          <year>2012</year>
<volume>29</volume>
<issue>2</issue>
<fpage>255</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">22330830</pub-id>
</element-citation>
</ref>
<ref id="CR274">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria</article-title>
<source/>J Alzheimers Dis
          <year>2014</year>
<volume>40</volume>
<issue>4</issue>
<fpage>765</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="pmid">24577474</pub-id>
</element-citation>
</ref>
<ref id="CR275">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mallinson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Robinette</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Gilfillan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Sudhakar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zinselmeyer</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Holtzman</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Cirrito</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Colonna</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model</article-title>
<source/>Cell
          <year>2015</year>
<volume>160</volume>
<issue>6</issue>
<fpage>1061</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.01.049</pub-id>
<pub-id pub-id-type="pmid">25728668</pub-id>
</element-citation>
</ref>
<ref id="CR276">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Suo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis</article-title>
<source/>Neurosci Lett
          <year>2016</year>
<volume>610</volume>
<fpage>200</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2015.11.014</pub-id>
<pub-id pub-id-type="pmid">26592479</pub-id>
</element-citation>
</ref>
<ref id="CR277">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willhite</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Karyakina</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Yokel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Yenugadhati</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wisniewski</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Momoli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Krewski</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts</article-title>
<source/>Crit Rev Toxicol
          <year>2014</year>
<volume>44</volume>
<issue>Suppl 4</issue>
<fpage>1</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.3109/10408444.2014.934439</pub-id>
<pub-id pub-id-type="pmid">25233067</pub-id>
</element-citation>
</ref>
<ref id="CR278">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meaburn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ronald</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jeffries</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schalkwyk</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>495</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.41</pub-id>
<pub-id pub-id-type="pmid">23608919</pub-id>
</element-citation>
</ref>
<ref id="CR279">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Inflammasomes and human autoimmunity: A comprehensive review</article-title>
<source/>J Autoimmun
          <year>2015</year>
<volume>61</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2015.05.001</pub-id>
<pub-id pub-id-type="pmid">26005048</pub-id>
</element-citation>
</ref>
<ref id="CR280">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Higashimori</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders</article-title>
<source/>J Neurodev Disord
          <year>2013</year>
<volume>5</volume>
<issue>1</issue>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-5-22</pub-id>
<pub-id pub-id-type="pmid">23988237</pub-id>
</element-citation>
</ref>
<ref id="CR281">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasuda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tsutsui</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Assessment of infantile mineral imbalances in autism spectrum disorders (ASDs)</article-title>
<source/>Int J Environ Res Public Health
          <year>2013</year>
<volume>10</volume>
<issue>11</issue>
<fpage>6027</fpage>
<lpage>6043</lpage>
<pub-id pub-id-type="doi">10.3390/ijerph10116027</pub-id>
<pub-id pub-id-type="pmid">24284360</pub-id>
</element-citation>
</ref>
<ref id="CR282">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasui</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kihira</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Calcium, magnesium and aluminum concentrations in Parkinson's disease</article-title>
<source/>Neurotoxicology
          <year>1992</year>
<volume>13</volume>
<issue>3</issue>
<fpage>593</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">1475063</pub-id>
</element-citation>
</ref>
<ref id="CR283">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yousef</surname>
<given-names>MI</given-names>
</name>
</person-group>
<article-title>Aluminium-induced changes in hemato-biochemical parameters, lipid peroxidation and enzyme activities of male rabbits: protective role of ascorbic acid</article-title>
<source/>Toxicology
          <year>2004</year>
<volume>199</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2004.02.014</pub-id>
<pub-id pub-id-type="pmid">15125998</pub-id>
</element-citation>
</ref>
<ref id="CR284">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats</article-title>
<source/>J Biomed Sci
          <year>2012</year>
<volume>19</volume>
<fpage>51</fpage>
<pub-id pub-id-type="doi">10.1186/1423-0127-19-51</pub-id>
<pub-id pub-id-type="pmid">22613782</pub-id>
</element-citation>
</ref>
<ref id="CR285">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yumoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kakimi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ohsaki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer’s disease</article-title>
<source/>J Inorg Biochem
          <year>2009</year>
<volume>103</volume>
<issue>11</issue>
<fpage>1579</fpage>
<lpage>1584</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinorgbio.2009.07.023</pub-id>
<pub-id pub-id-type="pmid">19744735</pub-id>
</element-citation>
</ref>
<ref id="CR286">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zafrir</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Agmon-Levin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shilton</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases</article-title>
<source/>Lupus
          <year>2012</year>
<volume>21</volume>
<issue>2</issue>
<fpage>146</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1177/0961203311429318</pub-id>
<pub-id pub-id-type="pmid">22235045</pub-id>
</element-citation>
</ref>
<ref id="CR287">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Moftah</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kandeel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bassiouny</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation</article-title>
<source/>BMC Neurosci
          <year>2013</year>
<volume>14</volume>
<issue>1</issue>
<fpage>26</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2202-14-26</pub-id>
<pub-id pub-id-type="pmid">23497276</pub-id>
</element-citation>
</ref>
<ref id="CR288">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>APP processing in Alzheimer's disease</article-title>
<source/>Mol Brain
          <year>2011</year>
<volume>4</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-4-3</pub-id>
<pub-id pub-id-type="pmid">21214928</pub-id>
</element-citation>
</ref>
<ref id="CR289">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hisatome</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells</article-title>
<source/>Mol Cell Endocrinol
          <year>2013</year>
<volume>375</volume>
<issue>1–2</issue>
<fpage>89</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2013.04.027</pub-id>
<pub-id pub-id-type="pmid">23707617</pub-id>
</element-citation>
</ref>
<ref id="CR290">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>TREM2 signaling, miRNA-34a and the extinction of phagocytosis</article-title>
<source/>Front Cell Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>131</fpage>
<pub-id pub-id-type="pmid">24009555</pub-id>
</element-citation>
</ref>
<ref id="CR291">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Dua</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alexandrov</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Regulation of TREM2 expression by an NF-small ka, CyrillicB-sensitive miRNA-34a</article-title>
<source/>Neuroreport
          <year>2013</year>
<volume>24</volume>
<issue>6</issue>
<fpage>318</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0b013e32835fb6b0</pub-id>
<pub-id pub-id-type="pmid">23462268</pub-id>
</element-citation>
</ref>
<ref id="CR292">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dua</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer’s disease (AD) and in primary human neuronal-glial (HNG) cells</article-title>
<source/>Mol Neurobiol
          <year>2014</year>
<volume>50</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-013-8595-3</pub-id>
<pub-id pub-id-type="pmid">24293102</pub-id>
</element-citation>
</ref>
<ref id="CR293">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhubi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Epigenetic mechanisms in autism spectrum disorder</article-title>
<source/>Int Rev Neurobiol
          <year>2014</year>
<volume>115</volume>
<fpage>203</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/B978-0-12-801311-3.00006-8</pub-id>
<pub-id pub-id-type="pmid">25131546</pub-id>
</element-citation>
</ref>
<ref id="CR294">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zielke</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Tildon</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Max</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>A glutamatergic mechanism for aluminum toxicity in astrocytes</article-title>
<source/>Mol Chem Neuropathol
          <year>1993</year>
<volume>19</volume>
<issue>3</issue>
<fpage>219</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1007/BF03160001</pub-id>
<pub-id pub-id-type="pmid">8104402</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>